word,tfidf
treatment,0.2450020365462401
disease,0.15750130920829722
cell,0.1407303364685248
10,0.1341677819181791
inclusion,0.1334386091903629
gvhd,0.1327094364625467
msc,0.12897229918089545
uveitis,0.10774900944226708
transplantation,0.10718839098898005
criteria,0.10448388794401656
days,0.10281335462208291
severe,0.1020841818942667
al,0.09993542624123132
transplant,0.09697997279955338
et,0.09632108419839026
mg,0.09187576370484003
cells,0.08968824552139146
12,0.08895907279357528
risk,0.08822990006575908
week,0.0865257197036387
anti,0.08531320915449432
randomized,0.08489315895451345
use,0.08407687857995083
acute,0.08385486369886193
kg,0.08093817278759717
efficacy,0.07999547670713768
bd,0.07673035520888716
month,0.07673035520888716
therapy,0.07583396369288384
arm,0.07510479096506764
stem,0.0750977944597619
active,0.07437561823725146
primary,0.07437561823725146
response,0.07364644550943528
refractory,0.07364644550943528
donor,0.07291727278161908
duration,0.07218810005380288
survival,0.07145892732598669
relapse,0.07145892732598669
allogeneic,0.07101639258694875
rate,0.06927140914253813
safety,0.06854223641472193
weeks,0.06708389095908955
hsct,0.06635471823127335
phase,0.06562554550345717
post,0.06562554550345717
added,0.06434324687539322
infection,0.0634380273200086
sponsor,0.06318222096685883
analysis,0.06197968186437621
secondary,0.06125050913656002
m12,0.061110672738437226
versus,0.060511359008452
haplo,0.05979216368092764
endpoint,0.059588467343071945
evaluate,0.05867768146274133
risks,0.05788562117381111
regimen,0.057760842689885995
included,0.05713962621938406
chronic,0.05687547276966288
marrow,0.056323345844821425
follow,0.0554171273140305
design,0.055010326371319994
effect,0.054690785095696165
group,0.05468795458621431
following,0.053229609130581924
expected,0.053176648825609324
oral,0.053176648825609324
16,0.05305822434657091
atg,0.052824479824750824
grade,0.052500436402765735
period,0.052500436402765735
conditioning,0.052500436402765735
year,0.052500436402765735
prophylaxis,0.05225981005275399
incidence,0.05142566359744565
age,0.05134297127989866
ii,0.05104209094713335
adalimumab,0.05060938322288302
matched,0.05060938322288302
ptcy,0.04971715748211843
24,0.04958374549150097
30,0.04958374549150097
m6,0.04950929373418799
data,0.04885457276368478
associated,0.04885457276368478
total,0.04885457276368478
cyclophosphamide,0.04816054209919513
effects,0.04816054209919513
20,0.048125400035868585
reduced,0.04767561618847732
failure,0.0473962273080524
graft,0.04571170097550724
ssc,0.04571170097550724
overall,0.045208709124603834
hla,0.04489542060094461
paris,0.04489542060094461
infectious,0.04489542060094461
rituximab,0.044890889889894335
informed,0.044890889889894335
scientific,0.044890889889894335
infusion,0.044079140226381985
consent,0.044079140226381985
reported,0.04375036366897144
life,0.04375036366897144
prospective,0.04350251279685362
hospitalization,0.04326285985181935
events,0.04302119094115525
methods,0.04246673868264282
compared,0.042446579477256725
36,0.042446579477256725
skin,0.042446579477256725
justification,0.04243916283270616
immune,0.04229201821333907
40,0.04229201821333907
immunosuppressive,0.04217458355134533
18,0.0416302991026941
adverse,0.04156284548552287
objectives,0.04143096456843202
m3,0.041257744778489994
unrelated,0.040833672757706684
injection,0.040833672757706684
leukemia,0.04039519045422122
pd,0.04039519045422122
fludarabine,0.04034090600563466
effective,0.04034090600563466
21,0.04034090600563466
site,0.04016553305937914
ap,0.04016553305937914
50,0.040104500029890494
hospital,0.03999773835356884
free,0.03999773835356884
sct,0.03999773835356884
objective,0.03942406723277933
investigator,0.03942406723277933
remission,0.039375327302074305
systemic,0.039375327302074305
vasculitis,0.039375327302074305
endpoints,0.03918145797900621
multicenter,0.03898419385175034
contraception,0.03898419385175034
treated,0.03864615457425811
test,0.03864615457425811
19,0.03864615457425811
high,0.03864615457425811
history,0.03850722845992399
complete,0.03791698184644192
hp,0.037802854644121545
participation,0.037802854644121545
bone,0.03759038968706866
care,0.03754889722988095
stage,0.03754889722988095
prednisone,0.03754889722988095
main,0.03718780911862573
iv,0.03718780911862573
saa,0.0369631418220344
participants,0.03667355091421333
treosulfan,0.03667355091421333
function,0.03591633648075569
randomization,0.035729463662993344
publique,0.035216319883167216
recently,0.035216319883167216
tocilizumab,0.03510005610619306
anemia,0.03510005610619306
specific,0.035000290935177154
evidence,0.035000290935177154
increased,0.035000290935177154
cd,0.034839873368502666
100,0.03428377573163043
funding,0.034225131316698514
busulfan,0.034225131316698514
compare,0.03418054576895642
negative,0.03392303459564733
comparing,0.03392303459564733
best,0.033541945479544776
placebo,0.033541945479544776
quality,0.033541945479544776
visit,0.0334674953570678
host,0.033144771654745615
13,0.033144771654745615
mycophenolate,0.033006195822791996
abstinence,0.03285612606403058
acronym,0.03285612606403058
involvement,0.032812772751728586
m24,0.03210899754053482
carcinoma,0.03210899754053482
cases,0.03210899754053482
statistical,0.03210899754053482
22,0.032089357049936665
activity,0.03208360002391239
globulin,0.031896158605977554
2019,0.031896158605977554
mortality,0.031834934607942546
score,0.031834934607942546
major,0.031834934607942546
received,0.031834934607942546
insurance,0.03148712081136264
tnf,0.0313544272960962
potential,0.0313544272960962
renal,0.031172518277081326
national,0.031172518277081326
positive,0.031172518277081326
atlg,0.031073223426324015
women,0.031073223426324015
pregnancy,0.030714819398348754
showed,0.030714819398348754
infections,0.03062525456828001
population,0.03020237385881729
covid,0.03020237385881729
11,0.03020237385881729
adult,0.03020237385881729
doi,0.030118115558694696
health,0.02989608184046382
administration,0.02989608184046382
il,0.029533480190719955
coordinating,0.029533480190719955
monitoring,0.02938609348425466
25,0.02938609348425466
investigational,0.029338840731370663
mofetil,0.029338840731370663
groups,0.029166909112647632
complications,0.029166909112647632
hematopoietic,0.029166909112647632
intensity,0.029001675197902414
ist,0.028749110306026757
sexual,0.028749110306026757
centre,0.02856981310969203
baseline,0.02856981310969203
ref,0.02842200195851533
contraceptive,0.028352140983091155
agents,0.027965901083691614
organ,0.0277535327351294
long,0.0277535327351294
ks,0.0277535327351294
therapeutic,0.0277535327351294
48,0.0277535327351294
antibiotic,0.0277535327351294
identical,0.0277535327351294
treatments,0.02770856365701525
60,0.02770856365701525
lung,0.027505163185659997
sample,0.027505163185659997
26,0.027380105053358816
sars,0.026979390929199057
retinal,0.026979390929199057
observed,0.026979390929199057
ocular,0.026979390929199057
term,0.02693725236056677
80,0.02693725236056677
antibodies,0.02693725236056677
assess,0.02693725236056677
prevalence,0.026930126969480814
controlled,0.026930126969480814
monoclonal,0.026930126969480814
human,0.026588324412804662
benefit,0.026250218201382867
cancer,0.02612097198600414
requiring,0.02612097198600414
hiv,0.02598946256783356
hepatitis,0.02598946256783356
department,0.02598946256783356
tb,0.02598946256783356
promising,0.02598946256783356
demonstrated,0.02598946256783356
centers,0.02598946256783356
similar,0.025894352855270013
medicinal,0.025894352855270013
myeloid,0.025894352855270013
pulmonary,0.02567148563994933
aplastic,0.02567148563994933
donors,0.02567148563994933
70,0.025521045473566675
cryoglobulinemia,0.025521045473566675
reduction,0.02530469161144151
drugs,0.024858578741059217
ric,0.024808123360204763
agent,0.024808123360204763
cardiac,0.024791872745750485
product,0.024754646867093996
improvement,0.024754646867093996
hours,0.024754646867093996
intrauterine,0.024642094548022936
centres,0.024642094548022936
sources,0.024642094548022936
yes,0.024642094548022936
interventions,0.024642094548022936
higher,0.02448841123687888
behcets,0.024062700017934292
center,0.02383780809423866
28,0.02382280462684841
haploidentical,0.02382280462684841
changes,0.02382280462684841
confirmed,0.02367213086231625
inflammation,0.02367213086231625
corticosteroids,0.02367213086231625
experimental,0.02367213086231625
17,0.02367213086231625
pregnant,0.023626784152575964
benefits,0.023626784152575964
hypersensitivity,0.023626784152575964
end,0.023333527290118103
retrospective,0.02327308929535499
laherparepvec,0.02292096932138333
biological,0.02292096932138333
talimogene,0.02292096932138333
mud,0.02292096932138333
ml,0.02292096932138333
inflammatory,0.02285585048775362
reference,0.02285585048775362
belimumab,0.02285585048775362
receiving,0.02285585048775362
absence,0.02285585048775362
approach,0.02285585048775362
min,0.02278703051263761
breast,0.02278703051263761
eligible,0.02278703051263761
exclusion,0.02278703051263761
optimal,0.022604354562301917
management,0.022604354562301917
nausea,0.022445444944947168
2020,0.022445444944947168
female,0.022445444944947168
ci,0.022445444944947168
reactions,0.022445444944947168
line,0.022039570113190993
threatening,0.022039570113190993
iii,0.022039570113190993
tumor,0.022039570113190993
creatinine,0.022004130548527994
currently,0.022004130548527994
uncontrolled,0.022004130548527994
receive,0.022004130548527994
known,0.022004130548527994
arms,0.022004130548527994
cov,0.022004130548527994
reconstitution,0.022004130548527994
m1,0.022004130548527994
aged,0.022004130548527994
mice,0.021904084042687053
tcz,0.021904084042687053
levels,0.02187518183448572
progression,0.02187518183448572
syndrome,0.02187518183448572
toxicity,0.02187518183448572
considered,0.02187518183448572
available,0.02187518183448572
option,0.02175125639842681
phrc,0.02175125639842681
strategy,0.02175125639842681
hormonal,0.02175125639842681
42,0.021264105737318365
published,0.021264105737318365
source,0.021223289738628363
previous,0.021223289738628363
subject,0.021223289738628363
m2,0.021223289738628363
outcomes,0.021223289738628363
international,0.021223289738628363
assessed,0.021146009106669535
level,0.021146009106669535
saint,0.021087291775672666
aa,0.021087291775672666
pain,0.02071548228421601
european,0.02071548228421601
virus,0.02071548228421601
prevent,0.02071548228421601
35,0.02071548228421601
m0,0.02071548228421601
injectable,0.02053507879001911
lesions,0.020416836378853342
peripheral,0.020416836378853342
early,0.020416836378853342
outcome,0.020416836378853342
current,0.020416836378853342
eye,0.020416836378853342
corticosteroid,0.020416836378853342
serum,0.020407009364065733
sle,0.020407009364065733
aiec,0.020407009364065733
antibody,0.020407009364065733
terms,0.020407009364065733
sparing,0.020407009364065733
shown,0.02017045300281733
sibling,0.02017045300281733
transplanted,0.02017045300281733
treat,0.02017045300281733
95,0.02017045300281733
france,0.019687663651037152
steroid,0.019687663651037152
increase,0.019687663651037152
mammography,0.01967970817000521
written,0.01967970817000521
despite,0.01967970817000521
signed,0.01967970817000521
combination,0.01967970817000521
improve,0.01967970817000521
thymocyte,0.01967970817000521
resistant,0.01967970817000521
extension,0.01967970817000521
immunosuppression,0.01967970817000521
size,0.019590728989503106
camostat,0.019590728989503106
heart,0.019590728989503106
louis,0.019590728989503106
need,0.019590728989503106
respiratory,0.019253614229961996
infliximab,0.019253614229961996
clearance,0.019253614229961996
aml,0.019253614229961996
05,0.019253614229961996
society,0.01916607353735117
mm3,0.01916607353735117
children,0.01916607353735117
board,0.01916607353735117
23,0.01916607353735117
biologics,0.01916607353735117
ada,0.01916607353735117
assessment,0.01895849092322096
probability,0.01895849092322096
improved,0.018901427322060772
highly,0.018901427322060772
head,0.018901427322060772
older,0.018901427322060772
fibrosis,0.018901427322060772
open,0.018901427322060772
aes,0.018901427322060772
childbearing,0.018901427322060772
tomosynthesis,0.018901427322060772
engraftment,0.018774448614940476
evaluated,0.018774448614940476
having,0.018774448614940476
45,0.018643934055794408
median,0.018643934055794408
simons,0.018643934055794408
intravenous,0.018643934055794408
diagnosis,0.018643934055794408
impact,0.018336775457106665
profile,0.018336775457106665
recent,0.018336775457106665
medical,0.01822931819540477
single,0.017958168240377846
therapies,0.017958168240377846
pr,0.017958168240377846
obtained,0.017958168240377846
usual,0.017958168240377846
low,0.017958168240377846
baltimore,0.01779706828468323
power,0.01779706828468323
diarrhea,0.01779706828468323
blindness,0.01779706828468323
ifx,0.01779706828468323
multicentre,0.01779706828468323
reducing,0.017720088114431973
small,0.017720088114431973
tuberculosis,0.017720088114431973
public,0.017720088114431973
cd38,0.017720088114431973
significantly,0.017720088114431973
urinary,0.017720088114431973
subcutaneously,0.017608159941583608
administered,0.017608159941583608
myeloablative,0.017608159941583608
vs,0.017608159941583608
adults,0.017608159941583608
bayesian,0.017608159941583608
additional,0.017500145467588577
prca,0.017500145467588577
disorders,0.017419936684251333
expression,0.017419936684251333
better,0.017419936684251333
grfs,0.017419936684251333
french,0.017419936684251333
setting,0.017419936684251333
lymphocyte,0.017419936684251333
niu,0.017419936684251333
w55,0.017419936684251333
occurrence,0.017141887865815216
mds,0.017141887865815216
significant,0.017141887865815216
macular,0.016770972739772388
reaction,0.016572385827372808
old,0.016572385827372808
protein,0.016572385827372808
acquired,0.016572385827372808
stopped,0.016572385827372808
strong,0.016572385827372808
bilirubin,0.016572385827372808
l1,0.016572385827372808
tissue,0.016572385827372808
vaccine,0.016538748906803173
past,0.016538748906803173
biologic,0.016538748906803173
malignancy,0.016538748906803173
morbidity,0.016538748906803173
myelofibrosis,0.016538748906803173
partner,0.016538748906803173
vitro,0.016538748906803173
fr,0.016538748906803173
fatigue,0.016538748906803173
37,0.016538748906803173
demonstrate,0.016503097911395998
dr,0.01642806303201529
myelodysplastic,0.01642806303201529
sided,0.01642806303201529
103,0.01642806303201529
party,0.01642806303201529
thiotepa,0.01642806303201529
progestogen,0.01642806303201529
methotrexate,0.01642806303201529
presence,0.01632560749125259
pembrolizumab,0.01632560749125259
symptoms,0.01632560749125259
comparison,0.01632560749125259
vascular,0.01632560749125259
change,0.01632560749125259
factors,0.01632560749125259
posterior,0.016041800011956195
doses,0.016041800011956195
conventional,0.015586259138540663
addition,0.015586259138540663
initial,0.015586259138540663
role,0.015586259138540663
mesylate,0.015586259138540663
context,0.015586259138540663
stopping,0.015586259138540663
adequate,0.015586259138540663
hr,0.015536611713162007
cd8,0.015536611713162007
antigen,0.015536611713162007
sclerosis,0.015536611713162007
planned,0.015536611713162007
derived,0.015536611713162007
2014,0.015509327116689958
2016,0.015509327116689958
classification,0.015509327116689958
2012,0.015509327116689958
manifestations,0.015509327116689958
viral,0.015509327116689958
visual,0.015509327116689958
transfusion,0.015509327116689958
abnormalities,0.015357409699174377
basal,0.015357409699174377
intestinal,0.015357409699174377
2018,0.015357409699174377
situ,0.015357409699174377
curative,0.015357409699174377
tract,0.015357409699174377
young,0.015357409699174377
mmhg,0.015357409699174377
multi,0.015357409699174377
short,0.015357409699174377
aphp,0.015357409699174377
prognosis,0.015357409699174377
properties,0.015357409699174377
remains,0.015357409699174377
procedure,0.015312627284140005
maladies,0.015059057779347348
live,0.015059057779347348
working,0.015059057779347348
biotherapies,0.015059057779347348
recurrent,0.015059057779347348
sites,0.01469304674212733
liver,0.01469304674212733
type,0.01469304674212733
selection,0.01469304674212733
isatuximab,0.01469304674212733
required,0.01469304674212733
red,0.01469304674212733
106,0.014669420365685332
lupus,0.014669420365685332
endemic,0.014669420365685332
described,0.014669420365685332
decreased,0.014669420365685332
respectively,0.014669420365685332
common,0.014669420365685332
recipient,0.014669420365685332
weight,0.014669420365685332
provide,0.014669420365685332
signs,0.014583454556323816
rates,0.014583454556323816
event,0.014583454556323816
pre,0.014583454556323816
label,0.014500837598951207
fever,0.014500837598951207
interferon,0.014500837598951207
2005,0.014500837598951207
psychiatric,0.014500837598951207
approved,0.014500837598951207
pediatric,0.014500837598951207
mscs,0.014500837598951207
mmf,0.014500837598951207
sight,0.014500837598951207
immunomodulatory,0.014500837598951207
interventional,0.014500837598951207
summary,0.014176070491545577
insufficiency,0.014176070491545577
nrm,0.014176070491545577
transfusions,0.0138767663675647
ratio,0.0138767663675647
antibiotics,0.0138767663675647
body,0.0138767663675647
mean,0.0138767663675647
evaluation,0.0138767663675647
committee,0.0138767663675647
count,0.013854281828507625
anterior,0.013854281828507625
second,0.013854281828507625
poor,0.013854281828507625
steroids,0.013854281828507625
injections,0.013752581592829998
worsening,0.013752581592829998
repeated,0.013752581592829998
lower,0.013752581592829998
maximum,0.013752581592829998
cumulative,0.013752581592829998
cure,0.013752581592829998
cutaneous,0.013752581592829998
mismatch,0.013752581592829998
underlying,0.013752581592829998
diseases,0.013752581592829998
estimate,0.013752581592829998
interim,0.013752581592829998
cellular,0.013690052526679408
practical,0.013690052526679408
production,0.013690052526679408
series,0.013690052526679408
blaise,0.013690052526679408
sterilization,0.013690052526679408
coverage,0.013690052526679408
31,0.013690052526679408
equivalent,0.013465063484740407
hemoglobin,0.013465063484740407
cohort,0.013465063484740407
forms,0.013465063484740407
induction,0.013465063484740407
inactive,0.013465063484740407
participate,0.013465063484740407
des,0.013465063484740407
orally,0.013465063484740407
dl,0.013465063484740407
malignancies,0.013465063484740407
m9,0.013465063484740407
2017,0.013465063484740407
death,0.013125109100691434
date,0.013125109100691434
evolution,0.013125109100691434
edema,0.013125109100691434
status,0.01306048599300207
different,0.01306048599300207
tolerance,0.01306048599300207
classic,0.01306048599300207
present,0.01306048599300207
report,0.01306048599300207
inhibitor,0.01306048599300207
troubles,0.01299473128391678
device,0.01299473128391678
distinct,0.01299473128391678
internal,0.01299473128391678
article,0.01299473128391678
cervix,0.01299473128391678
vomiting,0.01299473128391678
hydroxyurea,0.01299473128391678
tumors,0.01299473128391678
alpha,0.01299473128391678
sirolimus,0.01299473128391678
oedema,0.01299473128391678
ambulatory,0.01299473128391678
200,0.01299473128391678
pcr,0.012835742819974665
target,0.012835742819974665
left,0.012835742819974665
individuals,0.012835742819974665
enrolled,0.012835742819974665
allo,0.012835742819974665
combined,0.012835742819974665
abo,0.012835742819974665
association,0.012835742819974665
medicine,0.012835742819974665
ventricular,0.012429289370529608
scd,0.012429289370529608
w12,0.012429289370529608
chest,0.012429289370529608
cost,0.012429289370529608
lines,0.012429289370529608
male,0.012429289370529608
men,0.012429289370529608
advanced,0.012429289370529608
legal,0.012429289370529608
collection,0.012395936372875243
plasma,0.012395936372875243
followed,0.012395936372875243
78,0.012321047274011468
azathioprine,0.012321047274011468
grafts,0.012321047274011468
tel,0.012321047274011468
email,0.012321047274011468
asthenia,0.012321047274011468
antagonists,0.012321047274011468
melanoma,0.012321047274011468
w48,0.012321047274011468
complicated,0.012321047274011468
curatorship,0.012321047274011468
pneumonia,0.012321047274011468
transdermal,0.012321047274011468
ius,0.012321047274011468
depletion,0.012321047274011468
scope,0.012321047274011468
good,0.01224420561843944
appendix,0.01224420561843944
exposed,0.01224420561843944
injected,0.01224420561843944
double,0.01224420561843944
decrease,0.01224420561843944
partial,0.01224420561843944
reduce,0.01224420561843944
graall,0.01191890404711933
2008,0.01191890404711933
hopital,0.01191890404711933
ebv,0.01191890404711933
lymphocytes,0.01191890404711933
measured,0.01191890404711933
kidney,0.01191890404711933
mri,0.01191890404711933
uti,0.011813392076287982
uc,0.011813392076287982
breastfeeding,0.011813392076287982
2021,0.011813392076287982
containing,0.011813392076287982
anakinra,0.011813392076287982
d0,0.011813392076287982
failed,0.011813392076287982
suspected,0.011813392076287982
stable,0.011813392076287982
investigated,0.011813392076287982
rationale,0.011813392076287982
inclusions,0.011813392076287982
chimerism,0.011666763645059051
scale,0.01142792524387681
counts,0.01142792524387681
given,0.01142792524387681
infusions,0.01142792524387681
performance,0.01142792524387681
does,0.011393515256318805
mainly,0.011393515256318805
abnormal,0.011393515256318805
2015,0.011393515256318805
cd4,0.011393515256318805
questionnaire,0.011393515256318805
ct,0.011393515256318805
prevention,0.011393515256318805
action,0.011393515256318805
la,0.011393515256318805
ciprofloxacin,0.011393515256318805
inhibition,0.011393515256318805
schedule,0.011393515256318805
lymphoma,0.011393515256318805
large,0.011393515256318805
ktr,0.011393515256318805
intermediate,0.011002065274263997
acuity,0.011002065274263997
65,0.011002065274263997
difference,0.011002065274263997
sarcoma,0.011002065274263997
bmt,0.011002065274263997
screening,0.011002065274263997
analyses,0.011002065274263997
os,0.011002065274263997
aims,0.011002065274263997
procedures,0.011002065274263997
grafalon,0.011002065274263997
hypertension,0.011002065274263997
clinically,0.011002065274263997
ad,0.010952042021343526
pathway,0.010952042021343526
w25,0.010952042021343526
iud,0.010952042021343526
resolved,0.010952042021343526
cbt,0.010952042021343526
led,0.010952042021343526
52,0.010952042021343526
weekly,0.010952042021343526
30ml,0.010952042021343526
remain,0.010952042021343526
ag,0.010952042021343526
copy,0.010952042021343526
odv,0.010952042021343526
affiliation,0.010952042021343526
upper,0.010952042021343526
security,0.010952042021343526
reproductive,0.010952042021343526
hbv,0.010952042021343526
nyha,0.010952042021343526
detect,0.010952042021343526
multiple,0.01093759091724286
tnfa,0.010632052868659182
needed,0.010632052868659182
cdeis,0.010632052868659182
preferred,0.010632052868659182
progressive,0.010632052868659182
umbilical,0.010632052868659182
w1,0.010632052868659182
ecog,0.010632052868659182
cord,0.010632052868659182
auto,0.010632052868659182
rare,0.010632052868659182
pyelonephritis,0.010632052868659182
situation,0.010632052868659182
conducted,0.010632052868659182
dysfunction,0.010632052868659182
mrss,0.010632052868659182
initially,0.010632052868659182
indication,0.010632052868659182
sun,0.010611644869314181
laboratory,0.010611644869314181
proportion,0.010611644869314181
neurological,0.010611644869314181
recommended,0.010611644869314181
unless,0.010357741142108004
idiopathic,0.010357741142108004
outside,0.010357741142108004
hepatic,0.010357741142108004
products,0.010357741142108004
immunosuppressants,0.010357741142108004
development,0.010357741142108004
neutropenia,0.010357741142108004
observational,0.010357741142108004
rejection,0.010357741142108004
illness,0.010357741142108004
intensive,0.010357741142108004
intravenously,0.010357741142108004
social,0.010357741142108004
superior,0.010357741142108004
stenosis,0.010357741142108004
arterial,0.010357741142108004
lack,0.010357741142108004
plus,0.010357741142108004
cervical,0.010357741142108004
120,0.010357741142108004
severity,0.010208418189426671
measures,0.010208418189426671
model,0.010208418189426671
daily,0.010208418189426671
concentration,0.010085226501408666
method,0.010085226501408666
point,0.010085226501408666
responders,0.010085226501408666
80mg,0.010085226501408666
imaging,0.010085226501408666
global,0.010085226501408666
corrected,0.010085226501408666
identified,0.010085226501408666
tomography,0.010085226501408666
initiation,0.010085226501408666
platelets,0.010085226501408666
costs,0.009795364494751553
iron,0.009795364494751553
allow,0.009795364494751553
central,0.009795364494751553
2013,0.009795364494751553
platelet,0.009795364494751553
onset,0.009795364494751553
chamber,0.009795364494751553
withdrawal,0.009795364494751553
course,0.009795364494751553
releasing,0.009583036768675585
81,0.009583036768675585
88,0.009583036768675585
reactivation,0.009583036768675585
29,0.009583036768675585
tubal,0.009583036768675585
ophthalmology,0.009583036768675585
rares,0.009583036768675585
csm,0.009583036768675585
hypothesize,0.009583036768675585
obstruction,0.009583036768675585
hematology,0.009583036768675585
baff,0.009583036768675585
registered,0.009583036768675585
clinicaltrials,0.009583036768675585
tbi,0.009583036768675585
mismatched,0.009583036768675585
significance,0.009583036768675585
supportive,0.009583036768675585
route,0.009583036768675585
intravaginal,0.009583036768675585
literature,0.009583036768675585
mondor,0.009583036768675585
solid,0.009583036768675585
salpetriere,0.009583036768675585
000,0.009583036768675585
pitie,0.009583036768675585
hcv,0.009583036768675585
behalf,0.009583036768675585
behcet,0.009583036768675585
aim,0.009583036768675585
cyp2c19,0.009583036768675585
caused,0.009583036768675585
value,0.00947924546161048
resolution,0.00947924546161048
samples,0.00947924546161048
vessel,0.00947924546161048
expert,0.009450713661030386
synthetic,0.009450713661030386
irradiation,0.009450713661030386
44,0.009450713661030386
5mg,0.009450713661030386
sepsis,0.009450713661030386
lifestyle,0.009450713661030386
serology,0.009450713661030386
squamous,0.009450713661030386
requires,0.009450713661030386
eu,0.009450713661030386
dependent,0.009450713661030386
ae,0.009450713661030386
hcg,0.009450713661030386
ovulation,0.009450713661030386
quantitative,0.009450713661030386
permanent,0.009450713661030386
excipients,0.009450713661030386
alat,0.009450713661030386
27,0.009450713661030386
code,0.009450713661030386
2x106,0.009450713661030386
regulation,0.009450713661030386
ray,0.009450713661030386
2010,0.009450713661030386
evaluating,0.009450713661030386
emergency,0.009450713661030386
direct,0.009321967027897204
bilateral,0.009321967027897204
w4,0.009321967027897204
condition,0.009321967027897204
40mg,0.009321967027897204
medication,0.009321967027897204
disorder,0.009321967027897204
alternative,0.009321967027897204
inferiority,0.009321967027897204
rifaximin,0.009321967027897204
range,0.009321967027897204
mild,0.009321967027897204
rules,0.009321967027897204
aminotransferase,0.009321967027897204
sae,0.009321967027897204
w8,0.009321967027897204
undergoing,0.009321967027897204
pressure,0.009168387728553332
ctcae,0.009168387728553332
ph,0.009168387728553332
estimated,0.009168387728553332
rapid,0.009168387728553332
acs,0.009168387728553332
absolute,0.009168387728553332
particular,0.009168387728553332
300,0.009168387728553332
meeting,0.009168387728553332
pan,0.009168387728553332
values,0.009168387728553332
needs,0.009168387728553332
induced,0.009168387728553332
thymoglobulin,0.009168387728553332
blinded,0.009168387728553332
surface,0.009168387728553332
able,0.008979084120188923
overload,0.008979084120188923
support,0.008979084120188923
factor,0.008979084120188923
eligibility,0.008979084120188923
responses,0.008979084120188923
characteristics,0.008979084120188923
interval,0.008750072733794289
previously,0.008750072733794289
109,0.008286192913686404
fertility,0.008286192913686404
w16,0.008286192913686404
fraction,0.008286192913686404
inform,0.008286192913686404
colonized,0.008286192913686404
targets,0.008286192913686404
diagnosed,0.008286192913686404
recipients,0.008286192913686404
lead,0.008286192913686404
stratified,0.008286192913686404
sampling,0.008286192913686404
w24,0.008286192913686404
sf,0.008286192913686404
leakage,0.008286192913686404
apn,0.008286192913686404
arthritis,0.008286192913686404
blind,0.008286192913686404
echocardiography,0.008286192913686404
dosage,0.008286192913686404
question,0.008286192913686404
affect,0.008286192913686404
urine,0.008286192913686404
gov,0.008286192913686404
prescribed,0.008286192913686404
identify,0.008286192913686404
efs,0.008286192913686404
persistent,0.008286192913686404
general,0.008286192913686404
characterize,0.008286192913686404
glomerular,0.008286192913686404
affiliated,0.008269374453401587
achieve,0.008269374453401587
cancers,0.008269374453401587
periods,0.008269374453401587
participated,0.008269374453401587
poorly,0.008269374453401587
162,0.008269374453401587
feeding,0.008269374453401587
frequent,0.008269374453401587
superiority,0.008269374453401587
asat,0.008269374453401587
dlco,0.008269374453401587
suggest,0.008269374453401587
substance,0.008269374453401587
sole,0.008269374453401587
43,0.008269374453401587
isolated,0.008269374453401587
specifically,0.008269374453401587
ebmt,0.008269374453401587
dramatically,0.008269374453401587
confirm,0.008269374453401587
delay,0.008269374453401587
healthy,0.008269374453401587
nih,0.008269374453401587
91,0.008269374453401587
allowed,0.008269374453401587
csf,0.008269374453401587
regardless,0.008269374453401587
allogenic,0.008269374453401587
clonal,0.008269374453401587
allergic,0.008269374453401587
regarding,0.008269374453401587
receptor,0.008269374453401587
individual,0.008269374453401587
180,0.008251548955697999
cytokine,0.008251548955697999
eyes,0.008251548955697999
analyzed,0.008251548955697999
consecutive,0.008251548955697999
toxicities,0.008251548955697999
autoimmune,0.008251548955697999
discontinuation,0.008251548955697999
team,0.008251548955697999
entry,0.008251548955697999
detected,0.008251548955697999
bcva,0.008251548955697999
proposed,0.008251548955697999
rapidly,0.008251548955697999
damage,0.008251548955697999
biopsy,0.008251548955697999
gene,0.008251548955697999
potentially,0.008251548955697999
cytokines,0.008251548955697999
fda,0.008214031516007645
infected,0.008214031516007645
blys,0.008214031516007645
adipose,0.008214031516007645
cocktail,0.008214031516007645
clinique,0.008214031516007645
pnh,0.008214031516007645
elt,0.008214031516007645
permitted,0.008214031516007645
38,0.008214031516007645
47,0.008214031516007645
largely,0.008214031516007645
debilitating,0.008214031516007645
pro,0.008214031516007645
transient,0.008214031516007645
recherche,0.008214031516007645
cystitis,0.008214031516007645
haematopoietic,0.008214031516007645
abuse,0.008214031516007645
chru,0.008214031516007645
unwilling,0.008214031516007645
addressing,0.008214031516007645
hemorrhagic,0.008214031516007645
publication,0.008214031516007645
5xuln,0.008214031516007645
selected,0.008214031516007645
envelope,0.008214031516007645
parents,0.008214031516007645
parenteral,0.008214031516007645
condoms,0.008214031516007645
compounds,0.008214031516007645
multicentric,0.008214031516007645
barrier,0.008214031516007645
valid,0.008214031516007645
abscess,0.008214031516007645
child,0.008214031516007645
75010,0.008214031516007645
cyp2d6,0.008214031516007645
visits,0.008162803745626295
cause,0.008162803745626295
biopsies,0.008162803745626295
nk,0.008162803745626295
considering,0.008162803745626295
right,0.008162803745626295
vitreous,0.008020900005978097
recommendations,0.008020900005978097
greater,0.008020900005978097
met,0.008020900005978097
cov2,0.007346523371063665
parameters,0.007346523371063665
presented,0.007346523371063665
percentage,0.007346523371063665
spartalizumab,0.007346523371063665
release,0.007346523371063665
regulatory,0.007346523371063665
delayed,0.007346523371063665
haze,0.007346523371063665
late,0.007346523371063665
voc,0.007334710182842666
possible,0.007334710182842666
coherence,0.007334710182842666
immunological,0.007334710182842666
endoscopic,0.007334710182842666
moderate,0.007334710182842666
directly,0.007334710182842666
like,0.007334710182842666
qol,0.007334710182842666
protection,0.007334710182842666
elderly,0.007334710182842666
standardization,0.007334710182842666
computed,0.007334710182842666
relapses,0.007334710182842666
chemotherapy,0.007334710182842666
2003,0.007334710182842666
hematological,0.007334710182842666
developed,0.007334710182842666
occurs,0.007334710182842666
future,0.007334710182842666
genetic,0.007334710182842666
capmatinib,0.007291727278161908
step,0.007291727278161908
150,0.007250418799475604
oct,0.007250418799475604
diabetes,0.007250418799475604
experienced,0.007250418799475604
experience,0.007250418799475604
mrd,0.007250418799475604
optimized,0.007250418799475604
equal,0.007250418799475604
contraindication,0.007250418799475604
safe,0.007250418799475604
cd20,0.007250418799475604
sante,0.007250418799475604
54,0.007250418799475604
shall,0.007250418799475604
segment,0.007250418799475604
markers,0.007250418799475604
antidepressant,0.007250418799475604
capacity,0.007250418799475604
bacteria,0.007250418799475604
alloimmunization,0.007250418799475604
accordance,0.007250418799475604
cyclosporine,0.007250418799475604
physician,0.007250418799475604
prognostic,0.007250418799475604
tested,0.007250418799475604
carried,0.007250418799475604
ejection,0.007250418799475604
adenocarcinoma,0.007250418799475604
sustained,0.007250418799475604
excluded,0.007250418799475604
hbs,0.007088035245772789
suggesting,0.007088035245772789
inspired,0.007088035245772789
pk,0.007088035245772789
guidelines,0.007088035245772789
72,0.007088035245772789
ultrasound,0.007088035245772789
mra,0.007088035245772789
various,0.007088035245772789
grading,0.007088035245772789
rna,0.007088035245772789
alive,0.007088035245772789
consistent,0.007088035245772789
field,0.007088035245772789
inferior,0.007088035245772789
increasing,0.007088035245772789
program,0.007088035245772789
pneumonitis,0.007088035245772789
apply,0.007088035245772789
incidences,0.007088035245772789
34,0.007088035245772789
deficiency,0.007088035245772789
subcutaneous,0.007088035245772789
mentioned,0.007088035245772789
metabolism,0.007088035245772789
hospitalized,0.007088035245772789
avenue,0.007088035245772789
documents,0.007088035245772789
transaminases,0.007088035245772789
sealed,0.007088035245772789
sickle,0.007088035245772789
log,0.007088035245772789
56,0.007088035245772789
dependence,0.007088035245772789
provides,0.007088035245772789
anticipated,0.007088035245772789
trsae,0.007088035245772789
propose,0.007088035245772789
appendices,0.007088035245772789
prolonged,0.007088035245772789
eventually,0.007088035245772789
participating,0.007088035245772789
particularly,0.007088035245772789
cataract,0.007088035245772789
02,0.007088035245772789
reviewed,0.007088035245772789
recruiting,0.007088035245772789
gastrointestinal,0.007088035245772789
filtration,0.007088035245772789
normalization,0.007088035245772789
relapsing,0.007088035245772789
vessels,0.007088035245772789
vh,0.007088035245772789
willingness,0.007088035245772789
cdai,0.007088035245772789
2009,0.007088035245772789
list,0.007088035245772789
leading,0.007088035245772789
condom,0.007088035245772789
thickness,0.007088035245772789
sodium,0.007088035245772789
transplants,0.006845026263339704
implantable,0.006845026263339704
sustainable,0.006845026263339704
farge,0.006845026263339704
assays,0.006845026263339704
paroxysmal,0.006845026263339704
drastically,0.006845026263339704
little,0.006845026263339704
solution,0.006845026263339704
intercourse,0.006845026263339704
50ml,0.006845026263339704
randomised,0.006845026263339704
creteil,0.006845026263339704
madrs,0.006845026263339704
ll,0.006845026263339704
rabbit,0.006845026263339704
2n,0.006845026263339704
presenting,0.006845026263339704
kroger,0.006845026263339704
cytopenias,0.006845026263339704
acting,0.006845026263339704
optimize,0.006845026263339704
vaccines,0.006845026263339704
diffuse,0.006845026263339704
difficult,0.006845026263339704
guardianship,0.006845026263339704
omeprazole,0.006845026263339704
reading,0.006845026263339704
recruitment,0.006845026263339704
rct,0.006845026263339704
did,0.006845026263339704
na,0.006845026263339704
naive,0.006845026263339704
nct02213705,0.006845026263339704
fulfilling,0.006845026263339704
bid,0.006845026263339704
consistently,0.006845026263339704
vasectomised,0.006845026263339704
tutorship,0.006845026263339704
consortium,0.006845026263339704
modalities,0.006845026263339704
consultation,0.006845026263339704
bichat,0.006845026263339704
focus,0.006845026263339704
willing,0.006845026263339704
venlafaxine,0.006845026263339704
firm,0.006845026263339704
visceral,0.006845026263339704
microbiological,0.006845026263339704
mucocutaneous,0.006845026263339704
types,0.006845026263339704
understanding,0.006845026263339704
bearing,0.006845026263339704
options,0.006845026263339704
symptomatic,0.006845026263339704
man,0.006845026263339704
anaemia,0.006845026263339704
information,0.006562554550345717
surgery,0.006530242996501035
33,0.006530242996501035
completed,0.006530242996501035
55,0.006530242996501035
calculated,0.006530242996501035
testing,0.006530242996501035
normal,0.006530242996501035
syndromes,0.006530242996501035
search,0.006417871409987333
01,0.006417871409987333
cerebral,0.006417871409987333
practice,0.006417871409987333
involving,0.006417871409987333
section,0.006417871409987333
allows,0.006417871409987333
nomenclature,0.006417871409987333
observations,0.006417871409987333
twice,0.006417871409987333
extra,0.006417871409987333
final,0.006417871409987333
hemolytic,0.006417871409987333
discontinued,0.006417871409987333
composite,0.006417871409987333
criterion,0.006417871409987333
hypothesis,0.006417871409987333
enrolment,0.006417871409987333
records,0.006214644685264804
acceptable,0.006214644685264804
w36,0.006214644685264804
birth,0.006214644685264804
birads,0.006214644685264804
binary,0.006214644685264804
minimal,0.006214644685264804
unique,0.006214644685264804
panel,0.006214644685264804
basis,0.006214644685264804
organs,0.006214644685264804
correlation,0.006214644685264804
necessary,0.006214644685264804
nb,0.006214644685264804
proteinuria,0.006214644685264804
proven,0.006214644685264804
metastatic,0.006214644685264804
discretion,0.006214644685264804
metabolic,0.006214644685264804
rank,0.006214644685264804
du,0.006214644685264804
limit,0.006214644685264804
49,0.006214644685264804
appears,0.006214644685264804
length,0.006214644685264804
lesion,0.006214644685264804
dependency,0.006214644685264804
success,0.006214644685264804
definition,0.006214644685264804
2011,0.006214644685264804
intervention,0.006214644685264804
d60,0.006214644685264804
cns,0.006214644685264804
cmv,0.006214644685264804
colon,0.006214644685264804
prednisolone,0.006214644685264804
targeting,0.006214644685264804
examinations,0.006214644685264804
expressed,0.005906696038143991
address,0.005906696038143991
standardized,0.005906696038143991
feasibility,0.005906696038143991
ig,0.005906696038143991
immunodeficiency,0.005906696038143991
issues,0.005906696038143991
kaposis,0.005906696038143991
classical,0.005906696038143991
claude,0.005906696038143991
lee,0.005906696038143991
subsequent,0.005906696038143991
lowest,0.005906696038143991
topical,0.005906696038143991
segmental,0.005906696038143991
magic,0.005906696038143991
linked,0.005906696038143991
l2,0.005906696038143991
centralized,0.005906696038143991
w35,0.005906696038143991
chu,0.005906696038143991
vellefaux,0.005906696038143991
philadelphia,0.005906696038143991
activated,0.005906696038143991
htlv,0.005906696038143991
household,0.005906696038143991
microbiota,0.005906696038143991
enterobacteriaceae,0.005906696038143991
bacterial,0.005906696038143991
erythematosus,0.005906696038143991
market,0.005906696038143991
digital,0.005906696038143991
anaphylactic,0.005906696038143991
md,0.005906696038143991
continued,0.005906696038143991
monthly,0.005906696038143991
alloreactive,0.005906696038143991
unable,0.005906696038143991
1mg,0.005906696038143991
error,0.005906696038143991
preinclusion,0.005906696038143991
preventing,0.005906696038143991
occur,0.005906696038143991
occlusion,0.005906696038143991
reached,0.005906696038143991
ac,0.005906696038143991
relation,0.005906696038143991
replete,0.005906696038143991
92,0.005906696038143991
reticulocytes,0.005906696038143991
brands,0.005906696038143991
demyelinating,0.005906696038143991
order,0.005833381822529526
historical,0.005713962621938405
ileal,0.005713962621938405
exposure,0.005713962621938405
kaposi,0.005713962621938405
frequency,0.005713962621938405
neutrophil,0.005713962621938405
neutrophils,0.005713962621938405
hospitalizations,0.005713962621938405
cycles,0.005713962621938405
unit,0.005713962621938405
review,0.005713962621938405
wbc,0.0055010326371319985
tolerated,0.0055010326371319985
allowing,0.0055010326371319985
measurement,0.0055010326371319985
dna,0.0055010326371319985
meet,0.0055010326371319985
candidate,0.0055010326371319985
500,0.0055010326371319985
replacement,0.0055010326371319985
determine,0.0055010326371319985
optical,0.0055010326371319985
account,0.0055010326371319985
recommendation,0.0055010326371319985
adaptive,0.0055010326371319985
cycle,0.0055010326371319985
person,0.0055010326371319985
biomarkers,0.0055010326371319985
especially,0.0055010326371319985
06,0.005476021010671763
lateral,0.005476021010671763
characterized,0.005476021010671763
characterization,0.005476021010671763
chance,0.005476021010671763
likely,0.005476021010671763
luznik,0.005476021010671763
logrank,0.005476021010671763
lives,0.005476021010671763
lymphoblastic,0.005476021010671763
member,0.005476021010671763
vegf,0.005476021010671763
express,0.005476021010671763
vasectomy,0.005476021010671763
anticipate,0.005476021010671763
dosing,0.005476021010671763
dominique,0.005476021010671763
mrna,0.005476021010671763
altered,0.005476021010671763
exact,0.005476021010671763
mol,0.005476021010671763
evaluations,0.005476021010671763
far,0.005476021010671763
ar,0.005476021010671763
mediated,0.005476021010671763
methylprednisolone,0.005476021010671763
miami,0.005476021010671763
fai2r,0.005476021010671763
v0,0.005476021010671763
mirna,0.005476021010671763
uvb,0.005476021010671763
million,0.005476021010671763
alanine,0.005476021010671763
pbsc,0.005476021010671763
inadequate,0.005476021010671763
affecting,0.005476021010671763
offers,0.005476021010671763
truly,0.005476021010671763
effector,0.005476021010671763
devillier,0.005476021010671763
devastating,0.005476021010671763
differences,0.005476021010671763
aspartate,0.005476021010671763
artery,0.005476021010671763
muscle,0.005476021010671763
favorable,0.005476021010671763
favour,0.005476021010671763
cd34,0.005476021010671763
interfere,0.005476021010671763
flexibility,0.005476021010671763
territory,0.005476021010671763
therapeutically,0.005476021010671763
thrombopenia,0.005476021010671763
parallel,0.005476021010671763
pathogenesis,0.005476021010671763
aggravation,0.005476021010671763
opportunity,0.005476021010671763
infarction,0.005476021010671763
empirical,0.005476021010671763
agree,0.005476021010671763
college,0.005476021010671763
assuming,0.005476021010671763
occurred,0.005476021010671763
53,0.005476021010671763
represents,0.005476021010671763
robin,0.005476021010671763
continuation,0.005476021010671763
10mg,0.005476021010671763
younger,0.005476021010671763
w6,0.005476021010671763
yielded,0.005476021010671763
certain,0.005476021010671763
w10,0.005476021010671763
sas,0.005476021010671763
consult,0.005476021010671763
rt,0.005476021010671763
rubi,0.005476021010671763
seropositivity,0.005476021010671763
simplicity,0.005476021010671763
baron,0.005476021010671763
resting,0.005476021010671763
slow,0.005476021010671763
redness,0.005476021010671763
recovered,0.005476021010671763
correctly,0.005476021010671763
hospitalier,0.005476021010671763
conceive,0.005476021010671763
heterosexual,0.005476021010671763
resistance,0.005476021010671763
herpes,0.005476021010671763
hemoglobinuria,0.005476021010671763
87,0.005476021010671763
reach,0.005476021010671763
raising,0.005476021010671763
hypotheses,0.005476021010671763
covid19,0.005476021010671763
protease,0.005476021010671763
produce,0.005476021010671763
ileocolonoscopies,0.005476021010671763
strategies,0.005476021010671763
39,0.005476021010671763
calcineurin,0.005476021010671763
gfr,0.005476021010671763
encouraging,0.005476021010671763
postero,0.005476021010671763
d14,0.005476021010671763
supplementary,0.005476021010671763
acts,0.005476021010671763
tacrolimus,0.005476021010671763
supporting,0.005476021010671763
comparatively,0.005476021010671763
tapering,0.005476021010671763
advance,0.005476021010671763
w30,0.005178870571054002
w20,0.005178870571054002
scan,0.005178870571054002
earlier,0.005178870571054002
hhv8,0.005178870571054002
registry,0.005178870571054002
rule,0.005178870571054002
growth,0.005178870571054002
conditions,0.005178870571054002
85,0.005178870571054002
comply,0.005178870571054002
recovery,0.005178870571054002
actg,0.005178870571054002
59,0.005178870571054002
died,0.005178870571054002
joint,0.005178870571054002
invasive,0.005178870571054002
effectiveness,0.005178870571054002
state,0.005178870571054002
pt,0.005178870571054002
average,0.005178870571054002
sub,0.005178870571054002
400,0.005178870571054002
fvc,0.005178870571054002
immunotherapy,0.005178870571054002
important,0.005178870571054002
preexisting,0.005178870571054002
ast,0.005178870571054002
targeted,0.005178870571054002
physical,0.005178870571054002
attenuated,0.005178870571054002
pga,0.005178870571054002
numbers,0.005178870571054002
microns,0.005178870571054002
angiography,0.005178870571054002
american,0.005178870571054002
nasal,0.005178870571054002
inference,0.005178870571054002
features,0.005178870571054002
uln,0.005178870571054002
thrombocytopenia,0.005178870571054002
affected,0.005178870571054002
eltrombopag,0.005178870571054002
tolerability,0.005178870571054002
digestive,0.005178870571054002
independent,0.0051042090947133354
sensitivity,0.0051042090947133354
adapted,0.0051042090947133354
start,0.0048976822473757765
place,0.0048976822473757765
obtain,0.0048976822473757765
index,0.0048976822473757765
measure,0.0048976822473757765
limited,0.0048976822473757765
applicable,0.004725356830515193
lymphoid,0.004725356830515193
antiviral,0.004725356830515193
local,0.004725356830515193
failures,0.004725356830515193
mm,0.004725356830515193
bolus,0.004725356830515193
involves,0.004725356830515193
knowledge,0.004725356830515193
lethargy,0.004725356830515193
pcra,0.004725356830515193
thoracic,0.004725356830515193
toxic,0.004725356830515193
assessing,0.004725356830515193
coli,0.004725356830515193
oesogastric,0.004725356830515193
titers,0.004725356830515193
father,0.004725356830515193
myocardial,0.004725356830515193
diameter,0.004725356830515193
intent,0.004725356830515193
neoplasia,0.004725356830515193
effusion,0.004725356830515193
institute,0.004725356830515193
alemtuzumab,0.004725356830515193
infiltrate,0.004725356830515193
excessive,0.004725356830515193
understand,0.004725356830515193
suggestive,0.004725356830515193
commonly,0.004725356830515193
pd1,0.004725356830515193
percent,0.004725356830515193
swab,0.004725356830515193
physicians,0.004725356830515193
suffering,0.004725356830515193
sufficient,0.004725356830515193
takes,0.004725356830515193
cytogenetic,0.004725356830515193
immunology,0.004725356830515193
immunophenotyping,0.004725356830515193
called,0.004725356830515193
cy,0.004725356830515193
randomisation,0.004725356830515193
rarely,0.004725356830515193
quantiferon,0.004725356830515193
stock,0.004725356830515193
st,0.004725356830515193
ileum,0.004725356830515193
365,0.004725356830515193
successive,0.004725356830515193
stop,0.004725356830515193
prophylactic,0.004725356830515193
project,0.004725356830515193
complication,0.004725356830515193
glaucoma,0.004725356830515193
reappearance,0.004725356830515193
accounting,0.004725356830515193
goal,0.004725356830515193
gp,0.004725356830515193
showing,0.004725356830515193
smpc,0.004725356830515193
reason,0.004725356830515193
reactive,0.004725356830515193
hematologic,0.004725356830515193
rest,0.004725356830515193
5ml,0.004725356830515193
73m2,0.004725356830515193
healthcare,0.004725356830515193
dyslipidemia,0.004725356830515193
haematological,0.004725356830515193
screened,0.004725356830515193
withdrawn,0.004725356830515193
1121,0.004725356830515193
w13,0.004725356830515193
version,0.004584193864276666
scores,0.004584193864276666
bleeding,0.004584193864276666
binding,0.004584193864276666
usually,0.004584193864276666
fact,0.004584193864276666
examination,0.004584193864276666
chosen,0.004584193864276666
nei,0.004584193864276666
nervous,0.004584193864276666
deterioration,0.004584193864276666
determined,0.004584193864276666
depression,0.004584193864276666
flare,0.004584193864276666
beta,0.004584193864276666
pathology,0.004584193864276666
define,0.004584193864276666
taking,0.004584193864276666
formula,0.004584193864276666
consumption,0.004584193864276666
complementary,0.004584193864276666
stroke,0.004584193864276666
gamma,0.004584193864276666
act,0.004584193864276666
activation,0.004584193864276666
provided,0.004584193864276666
recorded,0.004584193864276666
regression,0.004584193864276666
relative,0.004584193864276666
require,0.004584193864276666
responsible,0.004584193864276666
causes,0.004584193864276666
validated,0.004375036366897144
half,0.004143096456843202
consider,0.004143096456843202
sequential,0.004143096456843202
relationship,0.004143096456843202
conclusion,0.004143096456843202
chelation,0.004143096456843202
maintenance,0.004143096456843202
validate,0.004143096456843202
eradication,0.004143096456843202
requirements,0.004143096456843202
bilag,0.004143096456843202
enroll,0.004143096456843202
authorized,0.004143096456843202
gold,0.004143096456843202
corresponding,0.004143096456843202
approximately,0.004143096456843202
recurrence,0.004143096456843202
enzymes,0.004143096456843202
extensive,0.004143096456843202
missing,0.004143096456843202
cross,0.004143096456843202
avoid,0.004143096456843202
questionnaires,0.004143096456843202
radiotherapy,0.004143096456843202
rbc,0.004143096456843202
authorization,0.004143096456843202
minimum,0.004143096456843202
alt,0.004143096456843202
spontaneous,0.004143096456843202
hydrocortisone,0.004143096456843202
volume,0.004143096456843202
exploratory,0.004143096456843202
outpatient,0.004143096456843202
assay,0.004143096456843202
detection,0.004143096456843202
plasmapheresis,0.004143096456843202
ferritin,0.004143096456843202
immunosuppressant,0.004143096456843202
frequently,0.004143096456843202
functional,0.004143096456843202
61,0.004143096456843202
rodnan,0.004143096456843202
rheumatoid,0.004143096456843202
complement,0.004143096456843202
adherence,0.004143096456843202
prescription,0.004143096456843202
murine,0.004143096456843202
diagnostic,0.004143096456843202
circulating,0.004143096456843202
chorioretinal,0.004143096456843202
acr,0.004143096456843202
fludrocortisone,0.004143096456843202
newly,0.004143096456843202
efficient,0.004143096456843202
infiltration,0.004143096456843202
informative,0.004143096456843202
tests,0.004143096456843202
independence,0.004143096456843202
times,0.004143096456843202
white,0.004143096456843202
dsmb,0.004143096456843202
bio,0.004107015758003822
sfgm,0.004107015758003822
lymphopenia,0.004107015758003822
retrospectively,0.004107015758003822
manner,0.004107015758003822
ipss,0.004107015758003822
drci,0.004107015758003822
cb,0.004107015758003822
leukoencephalopathy,0.004107015758003822
registration,0.004107015758003822
hormone,0.004107015758003822
98,0.004107015758003822
refraining,0.004107015758003822
referral,0.004107015758003822
heterogeneity,0.004107015758003822
bortezomib,0.004107015758003822
council,0.004107015758003822
extensively,0.004107015758003822
argenteuil,0.004107015758003822
edta,0.004107015758003822
mathec,0.004107015758003822
mechanisms,0.004107015758003822
archiving,0.004107015758003822
binders,0.004107015758003822
remaining,0.004107015758003822
azoospermia,0.004107015758003822
remained,0.004107015758003822
relevant,0.004107015758003822
biologically,0.004107015758003822
confidence,0.004107015758003822
valuable,0.004107015758003822
variations,0.004107015758003822
58,0.004107015758003822
consist,0.004107015758003822
contraindications,0.004107015758003822
rescue,0.004107015758003822
represent,0.004107015758003822
146,0.004107015758003822
leukemic,0.004107015758003822
les,0.004107015758003822
appearance,0.004107015758003822
appear,0.004107015758003822
le,0.004107015758003822
septic,0.004107015758003822
zhang,0.004107015758003822
111,0.004107015758003822
run,0.004107015758003822
hbsag,0.004107015758003822
hb,0.004107015758003822
consisting,0.004107015758003822
guidance,0.004107015758003822
gut,0.004107015758003822
gvl,0.004107015758003822
105,0.004107015758003822
interstitial,0.004107015758003822
disappointing,0.004107015758003822
directed,0.004107015758003822
molecules,0.004107015758003822
mll,0.004107015758003822
modifying,0.004107015758003822
generally,0.004107015758003822
ethics,0.004107015758003822
proved,0.004107015758003822
starch,0.004107015758003822
staff,0.004107015758003822
ifn,0.004107015758003822
hypotension,0.004107015758003822
crucial,0.004107015758003822
hypothyroidism,0.004107015758003822
cox,0.004107015758003822
unwillingness,0.004107015758003822
untreated,0.004107015758003822
vaginal,0.004107015758003822
v5,0.004107015758003822
uveitic,0.004107015758003822
urgent,0.004107015758003822
authors,0.004107015758003822
relapsed,0.004107015758003822
concept,0.004107015758003822
spectrum,0.004107015758003822
soluble,0.004107015758003822
sponsors,0.004107015758003822
intravitreal,0.004107015758003822
correspondence,0.004107015758003822
approval,0.004107015758003822
competent,0.004107015758003822
transcripts,0.004107015758003822
mutations,0.004107015758003822
adding,0.004107015758003822
presentation,0.004107015758003822
preclude,0.004107015758003822
precludes,0.004107015758003822
immunes,0.004107015758003822
preliminary,0.004107015758003822
potassium,0.004107015758003822
plays,0.004107015758003822
cytopathogenic,0.004107015758003822
immunosuppressed,0.004107015758003822
comparisons,0.004107015758003822
cytotoxicity,0.004107015758003822
ulcerations,0.004107015758003822
ulcers,0.004107015758003822
62,0.004107015758003822
furthermore,0.004107015758003822
proportional,0.004107015758003822
proteins,0.004107015758003822
gained,0.004107015758003822
gave,0.004107015758003822
subset,0.004107015758003822
estrogen,0.004107015758003822
enhance,0.004107015758003822
multifocal,0.004107015758003822
underwent,0.004107015758003822
unblinding,0.004107015758003822
universite,0.004107015758003822
exceed,0.004107015758003822
progressing,0.004107015758003822
universal,0.004107015758003822
neurologic,0.004107015758003822
nephritis,0.004107015758003822
1st,0.004107015758003822
filiere,0.004107015758003822
placebos,0.004107015758003822
figure,0.004107015758003822
advantage,0.004107015758003822
hazard,0.004107015758003822
gray,0.004107015758003822
handle,0.004107015758003822
roughly,0.004107015758003822
ring,0.004107015758003822
groupe,0.004107015758003822
sud,0.004107015758003822
improvements,0.004107015758003822
decade,0.004107015758003822
consented,0.004107015758003822
nicolas,0.004107015758003822
foam,0.004107015758003822
tc,0.004107015758003822
designed,0.004107015758003822
alcohol,0.004107015758003822
innovative,0.004107015758003822
nowadays,0.004107015758003822
osteoporosis,0.004107015758003822
osseous,0.004107015758003822
techniques,0.004107015758003822
systematically,0.004107015758003822
phd,0.004107015758003822
developing,0.004107015758003822
dexamethasone,0.004107015758003822
inserm,0.004107015758003822
benlysta,0.004107015758003822
thoroughly,0.004107015758003822
2mg,0.004107015758003822
324,0.004107015758003822
terminal,0.004107015758003822
paracetamol,0.004107015758003822
demets,0.004107015758003822
cmu,0.004107015758003822
departments,0.004107015758003822
ahsct,0.004107015758003822
individualized,0.004107015758003822
induce,0.004107015758003822
toulouse,0.004107015758003822
fistula,0.004107015758003822
aggressive,0.004107015758003822
ago,0.004107015758003822
expecting,0.004107015758003822
expansion,0.004107015758003822
exists,0.004107015758003822
industrial,0.004107015758003822
liquid,0.004107015758003822
aom,0.004107015758003822
explained,0.004107015758003822
limiting,0.004107015758003822
lacking,0.004107015758003822
jh,0.004107015758003822
dysmetabolic,0.004107015758003822
lan,0.004107015758003822
warranted,0.004107015758003822
131,0.004107015758003822
exhaustive,0.004107015758003822
yellow,0.004107015758003822
loss,0.004081401872813147
specified,0.004081401872813147
appropriate,0.004081401872813147
starting,0.004081401872813147
concomitant,0.004081401872813147
taken,0.004081401872813147
www,0.003667355091421333
continue,0.003667355091421333
vital,0.003667355091421333
participant,0.003667355091421333
table,0.003667355091421333
beginning,0.003667355091421333
http,0.003667355091421333
authority,0.003667355091421333
choice,0.003667355091421333
models,0.003667355091421333
stay,0.003667355091421333
set,0.003667355091421333
crp,0.003667355091421333
silent,0.003667355091421333
sledai,0.003667355091421333
selena,0.003667355091421333
malignant,0.003667355091421333
documented,0.003667355091421333
infarct,0.003667355091421333
functions,0.003667355091421333
modified,0.003645863639080954
latent,0.0035440176228863944
lariboisiere,0.0035440176228863944
w5,0.0035440176228863944
existing,0.0035440176228863944
zone,0.0035440176228863944
larger,0.0035440176228863944
fleming,0.0035440176228863944
tp,0.0035440176228863944
oncolytic,0.0035440176228863944
ema,0.0035440176228863944
versions,0.0035440176228863944
explore,0.0035440176228863944
1500,0.0035440176228863944
lineage,0.0035440176228863944
confounders,0.0035440176228863944
framework,0.0035440176228863944
inhibitors,0.0035440176228863944
noninfectious,0.0035440176228863944
detecting,0.0035440176228863944
inefficacy,0.0035440176228863944
obrien,0.0035440176228863944
collaboration,0.0035440176228863944
policy,0.0035440176228863944
suggested,0.0035440176228863944
66,0.0035440176228863944
film,0.0035440176228863944
pi,0.0035440176228863944
pleural,0.0035440176228863944
fewer,0.0035440176228863944
cytopenia,0.0035440176228863944
diaphragm,0.0035440176228863944
process,0.0035440176228863944
actual,0.0035440176228863944
populations,0.0035440176228863944
clin,0.0035440176228863944
natural,0.0035440176228863944
n1,0.0035440176228863944
fecal,0.0035440176228863944
successfully,0.0035440176228863944
culture,0.0035440176228863944
futility,0.0035440176228863944
compatible,0.0035440176228863944
ctae,0.0035440176228863944
phenotypes,0.0035440176228863944
deep,0.0035440176228863944
decisions,0.0035440176228863944
2000,0.0035440176228863944
nerve,0.0035440176228863944
neuro,0.0035440176228863944
noted,0.0035440176228863944
fluorescein,0.0035440176228863944
flu,0.0035440176228863944
finally,0.0035440176228863944
findings,0.0035440176228863944
igg,0.0035440176228863944
igra,0.0035440176228863944
spot,0.0035440176228863944
ss,0.0035440176228863944
started,0.0035440176228863944
eular,0.0035440176228863944
undergo,0.0035440176228863944
projected,0.0035440176228863944
ctfg,0.0035440176228863944
studied,0.0035440176228863944
ileocolonoscopy,0.0035440176228863944
intraocular,0.0035440176228863944
archived,0.0035440176228863944
exam,0.0035440176228863944
accompanied,0.0035440176228863944
crohns,0.0035440176228863944
accepted,0.0035440176228863944
spending,0.0035440176228863944
components,0.0035440176228863944
reactivations,0.0035440176228863944
abdominal,0.0035440176228863944
conversely,0.0035440176228863944
register,0.0035440176228863944
entire,0.0035440176228863944
anc,0.0035440176228863944
med,0.0035440176228863944
courses,0.0035440176228863944
mdrd,0.0035440176228863944
gives,0.0035440176228863944
critical,0.0035440176228863944
protocols,0.0035440176228863944
crt,0.0035440176228863944
escalation,0.0035440176228863944
masquerade,0.0035440176228863944
marginal,0.0035440176228863944
reliability,0.0035440176228863944
blockade,0.0035440176228863944
majority,0.0035440176228863944
van,0.0035440176228863944
checked,0.0035440176228863944
m4,0.0035440176228863944
maintained,0.0035440176228863944
segments,0.0035440176228863944
hemagglutinins,0.0035440176228863944
rheumatism,0.0035440176228863944
respect,0.0035440176228863944
cardiovascular,0.0035440176228863944
resection,0.0035440176228863944
reports,0.0035440176228863944
repair,0.0035440176228863944
background,0.0035440176228863944
dropping,0.0035440176228863944
applies,0.0035440176228863944
apparition,0.0035440176228863944
aplasia,0.0035440176228863944
league,0.0035440176228863944
joints,0.0035440176228863944
001,0.0035440176228863944
scheme,0.0035440176228863944
75,0.0035440176228863944
york,0.0035440176228863944
1000,0.0035440176228863944
web,0.0035440176228863944
03,0.0035440176228863944
family,0.0032651214982505174
follows,0.0032651214982505174
notably,0.0032651214982505174
ensure,0.0032651214982505174
mixed,0.0032651214982505174
radiation,0.0032651214982505174
icu,0.0032651214982505174
uninjected,0.0032651214982505174
longer,0.003107322342632402
applied,0.003107322342632402
base,0.003107322342632402
drop,0.003107322342632402
deaths,0.003107322342632402
nephropathy,0.003107322342632402
sri,0.003107322342632402
controls,0.003107322342632402
epidemiology,0.003107322342632402
atrial,0.003107322342632402
intolerance,0.003107322342632402
glucocorticoids,0.003107322342632402
v3,0.003107322342632402
oxygen,0.003107322342632402
m15,0.003107322342632402
reporting,0.003107322342632402
c4,0.003107322342632402
determination,0.003107322342632402
dfs,0.003107322342632402
proportions,0.003107322342632402
fixed,0.003107322342632402
survey,0.003107322342632402
tubes,0.003107322342632402
osteonecrosis,0.003107322342632402
beneficial,0.003107322342632402
whichever,0.003107322342632402
forced,0.003107322342632402
resonance,0.003107322342632402
anxiety,0.003107322342632402
responding,0.003107322342632402
profiles,0.003107322342632402
ctc,0.003107322342632402
necrosis,0.003107322342632402
documentation,0.003107322342632402
borr,0.003107322342632402
world,0.003107322342632402
details,0.003107322342632402
admission,0.003107322342632402
microalbuminuria,0.003107322342632402
estimation,0.003107322342632402
d29,0.003107322342632402
phenotyping,0.003107322342632402
vasopressors,0.003107322342632402
magnetic,0.003107322342632402
transmission,0.003107322342632402
monotherapy,0.003107322342632402
initiated,0.003107322342632402
gammaglobulin,0.003107322342632402
indexed,0.0027505163185659993
attributed,0.0027505163185659993
collect,0.0027505163185659993
phenotypic,0.0027505163185659993
mechanical,0.0027505163185659993
implemented,0.0027505163185659993
correlated,0.0027505163185659993
immunogenicity,0.0027505163185659993
overlap,0.0027505163185659993
immediate,0.0027505163185659993
note,0.0027505163185659993
fully,0.0027505163185659993
ventilation,0.0027505163185659993
virological,0.0027505163185659993
unacceptable,0.0027505163185659993
reasons,0.0027505163185659993
respond,0.0027505163185659993
propensity,0.0027380105053358816
montpellier,0.0027380105053358816
mrd1,0.0027380105053358816
morphologic,0.0027380105053358816
programs,0.0027380105053358816
amenable,0.0027380105053358816
programme,0.0027380105053358816
professor,0.0027380105053358816
q4w,0.0027380105053358816
producing,0.0027380105053358816
interactions,0.0027380105053358816
mononuclear,0.0027380105053358816
monocular,0.0027380105053358816
ikzf1,0.0027380105053358816
dioxide,0.0027380105053358816
il6,0.0027380105053358816
im,0.0027380105053358816
qualitative,0.0027380105053358816
iga,0.0027380105053358816
pten,0.0027380105053358816
psychiatry,0.0027380105053358816
psoriasis,0.0027380105053358816
endocrinal,0.0027380105053358816
enhances,0.0027380105053358816
intolerant,0.0027380105053358816
intraveinously,0.0027380105053358816
hospitals,0.0027380105053358816
rectal,0.0027380105053358816
rectum,0.0027380105053358816
cooperation,0.0027380105053358816
coordinator,0.0027380105053358816
coronary,0.0027380105053358816
regurgitation,0.0027380105053358816
herpetic,0.0027380105053358816
molecule,0.0027380105053358816
disodium,0.0027380105053358816
display,0.0027380105053358816
hg,0.0027380105053358816
histologically,0.0027380105053358816
reliable,0.0027380105053358816
removal,0.0027380105053358816
removes,0.0027380105053358816
henri,0.0027380105053358816
axis,0.0027380105053358816
bacillus,0.0027380105053358816
balance,0.0027380105053358816
amylase,0.0027380105053358816
crocchiolo,0.0027380105053358816
cryostem,0.0027380105053358816
hypromellose,0.0027380105053358816
icbd,0.0027380105053358816
id,0.0027380105053358816
randomize,0.0027380105053358816
ras,0.0027380105053358816
mmr,0.0027380105053358816
mobilization,0.0027380105053358816
modulation,0.0027380105053358816
microsatellite,0.0027380105053358816
covariate,0.0027380105053358816
reaching,0.0027380105053358816
hydrochloride,0.0027380105053358816
hydroxyomeprazole,0.0027380105053358816
autoreactive,0.0027380105053358816
auxiliary,0.0027380105053358816
realization,0.0027380105053358816
court,0.0027380105053358816
accurate,0.0027380105053358816
recognition,0.0027380105053358816
recombinant,0.0027380105053358816
produced,0.0027380105053358816
inherited,0.0027380105053358816
blocking,0.0027380105053358816
nonsteroidal,0.0027380105053358816
water,0.0027380105053358816
bsas,0.0027380105053358816
burden,0.0027380105053358816
depend,0.0027380105053358816
aid,0.0027380105053358816
induces,0.0027380105053358816
organization,0.0027380105053358816
cyp3a4,0.0027380105053358816
packed,0.0027380105053358816
institutions,0.0027380105053358816
insulin,0.0027380105053358816
painful,0.0027380105053358816
panuveitis,0.0027380105053358816
pao2,0.0027380105053358816
brain,0.0027380105053358816
bregante,0.0027380105053358816
patch,0.0027380105053358816
pathways,0.0027380105053358816
patterns,0.0027380105053358816
origin,0.0027380105053358816
worldwide,0.0027380105053358816
10mm,0.0027380105053358816
110,0.0027380105053358816
zhou,0.0027380105053358816
kt,0.0027380105053358816
130,0.0027380105053358816
140,0.0027380105053358816
excised,0.0027380105053358816
cedex,0.0027380105053358816
cellulose,0.0027380105053358816
influence,0.0027380105053358816
novo,0.0027380105053358816
algorithm,0.0027380105053358816
100mg,0.0027380105053358816
104,0.0027380105053358816
depends,0.0027380105053358816
associations,0.0027380105053358816
assumption,0.0027380105053358816
office,0.0027380105053358816
ophthalmologic,0.0027380105053358816
ophthalmological,0.0027380105053358816
opportunistic,0.0027380105053358816
novel,0.0027380105053358816
myelodysplasia,0.0027380105053358816
arrhythmia,0.0027380105053358816
articles,0.0027380105053358816
articular,0.0027380105053358816
addressed,0.0027380105053358816
cytolysis,0.0027380105053358816
adherent,0.0027380105053358816
potency,0.0027380105053358816
predicted,0.0027380105053358816
predictive,0.0027380105053358816
increases,0.0027380105053358816
immunoglobulin,0.0027380105053358816
intermittent,0.0027380105053358816
interquartile,0.0027380105053358816
mydriasis,0.0027380105053358816
pressures,0.0027380105053358816
california,0.0027380105053358816
cancerologie,0.0027380105053358816
curves,0.0027380105053358816
cutanee,0.0027380105053358816
add,0.0027380105053358816
principle,0.0027380105053358816
immunity,0.0027380105053358816
indicate,0.0027380105053358816
pellets,0.0027380105053358816
percentages,0.0027380105053358816
percutaneous,0.0027380105053358816
network,0.0027380105053358816
petersen,0.0027380105053358816
pharmacokinetic,0.0027380105053358816
physiologic,0.0027380105053358816
adrenal,0.0027380105053358816
intensification,0.0027380105053358816
intensified,0.0027380105053358816
possibility,0.0027380105053358816
necessitating,0.0027380105053358816
implants,0.0027380105053358816
improves,0.0027380105053358816
advocated,0.0027380105053358816
pituitary,0.0027380105053358816
d28,0.0027380105053358816
plasmatic,0.0027380105053358816
pm,0.0027380105053358816
immunosuppressors,0.0027380105053358816
impairment,0.0027380105053358816
positivity,0.0027380105053358816
nc,0.0027380105053358816
thyroxine,0.0027380105053358816
antiinflammatory,0.0027380105053358816
ja,0.0027380105053358816
jak,0.0027380105053358816
colchicine,0.0027380105053358816
colitis,0.0027380105053358816
colloidal,0.0027380105053358816
225,0.0027380105053358816
titanium,0.0027380105053358816
tki,0.0027380105053358816
clones,0.0027380105053358816
merkel,0.0027380105053358816
cni,0.0027380105053358816
cognitive,0.0027380105053358816
ligands,0.0027380105053358816
ligation,0.0027380105053358816
lipase,0.0027380105053358816
locally,0.0027380105053358816
finding,0.0027380105053358816
transfusional,0.0027380105053358816
tribeca,0.0027380105053358816
city,0.0027380105053358816
tube,0.0027380105053358816
1h,0.0027380105053358816
cluster,0.0027380105053358816
complex,0.0027380105053358816
doubled,0.0027380105053358816
lytic,0.0027380105053358816
superficial,0.0027380105053358816
suppression,0.0027380105053358816
surveillance,0.0027380105053358816
survive,0.0027380105053358816
systolic,0.0027380105053358816
carriage,0.0027380105053358816
carry,0.0027380105053358816
categorical,0.0027380105053358816
thymoglobuline,0.0027380105053358816
jelly,0.0027380105053358816
jm,0.0027380105053358816
john,0.0027380105053358816
jp,0.0027380105053358816
lyon,0.0027380105053358816
formal,0.0027380105053358816
formulation,0.0027380105053358816
francois,0.0027380105053358816
tcr,0.0027380105053358816
2g,0.0027380105053358816
2nd,0.0027380105053358816
therapie,0.0027380105053358816
jean,0.0027380105053358816
vary,0.0027380105053358816
vedolizumab,0.0027380105053358816
echocardiographies,0.0027380105053358816
largest,0.0027380105053358816
leaving,0.0027380105053358816
washout,0.0027380105053358816
biocollection,0.0027380105053358816
chi,0.0027380105053358816
cava,0.0027380105053358816
vena,0.0027380105053358816
162mg,0.0027380105053358816
feature,0.0027380105053358816
challenge,0.0027380105053358816
characteristic,0.0027380105053358816
vitiligo,0.0027380105053358816
dysfunctions,0.0027380105053358816
dyspnea,0.0027380105053358816
expertise,0.0027380105053358816
ya,0.0027380105053358816
w2,0.0027380105053358816
nuclear,0.0027380105053358816
alkylating,0.0027380105053358816
leflunomide,0.0027380105053358816
notch1,0.0027380105053358816
cfu,0.0027380105053358816
2004,0.0027380105053358816
2007,0.0027380105053358816
kind,0.0027380105053358816
kinetic,0.0027380105053358816
undergone,0.0027380105053358816
unemployment,0.0027380105053358816
unite,0.0027380105053358816
unknown,0.0027380105053358816
chlorambucil,0.0027380105053358816
exceptions,0.0027380105053358816
exchanges,0.0027380105053358816
favourable,0.0027380105053358816
variability,0.0027380105053358816
chloride,0.0027380105053358816
chromosome,0.0027380105053358816
leucocytes,0.0027380105053358816
driven,0.0027380105053358816
judgement,0.0027380105053358816
justified,0.0027380105053358816
urgently,0.0027380105053358816
uropathogen,0.0027380105053358816
ustekinumab,0.0027380105053358816
v2,0.0027380105053358816
false,0.0027380105053358816
evasion,0.0027380105053358816
fbxw7,0.0027380105053358816
scanner,0.0027380105053358816
scleroderma,0.0027380105053358816
guarantees,0.0027380105053358816
guided,0.0027380105053358816
diverticulitis,0.0027380105053358816
dividing,0.0027380105053358816
mellitus,0.0027380105053358816
h1,0.0027380105053358816
h2,0.0027380105053358816
secreted,0.0027380105053358816
seen,0.0027380105053358816
competing,0.0027380105053358816
separated,0.0027380105053358816
sequence,0.0027380105053358816
5n,0.0027380105053358816
confirming,0.0027380105053358816
congestive,0.0027380105053358816
conjunction,0.0027380105053358816
600mg,0.0027380105053358816
bdca,0.0027380105053358816
meaningful,0.0027380105053358816
measurable,0.0027380105053358816
boundaries,0.0027380105053358816
begin,0.0027380105053358816
selecting,0.0027380105053358816
83,0.0027380105053358816
84,0.0027380105053358816
8g,0.0027380105053358816
microcrystalline,0.0027380105053358816
microenvironment,0.0027380105053358816
amplified,0.0027380105053358816
contraceptives,0.0027380105053358816
contrasting,0.0027380105053358816
revised,0.0027380105053358816
rhythm,0.0027380105053358816
rondelli,0.0027380105053358816
sale,0.0027380105053358816
hand,0.0027380105053358816
waiting,0.0027380105053358816
metabolizing,0.0027380105053358816
metastases,0.0027380105053358816
mfi,0.0027380105053358816
investigation,0.0027380105053358816
investigations,0.0027380105053358816
hazards,0.0027380105053358816
hbcab,0.0027380105053358816
73,0.0027380105053358816
7g,0.0027380105053358816
consists,0.0027380105053358816
contra,0.0027380105053358816
itac,0.0027380105053358816
etanercept,0.0027380105053358816
generated,0.0027380105053358816
genes,0.0027380105053358816
geno,0.0027380105053358816
genova,0.0027380105053358816
sterility,0.0027380105053358816
344,0.0027380105053358816
375,0.0027380105053358816
macrophages,0.0027380105053358816
bladder,0.0027380105053358816
behaviour,0.0027380105053358816
3n,0.0027380105053358816
3rd,0.0027380105053358816
subsets,0.0027380105053358816
substrate,0.0027380105053358816
successively,0.0027380105053358816
gammaglobulines,0.0027380105053358816
gastric,0.0027380105053358816
suicidal,0.0027380105053358816
suicide,0.0027380105053358816
catheter,0.0027380105053358816
catheterization,0.0027380105053358816
compartments,0.0027380105053358816
blast,0.0027380105053358816
sgot,0.0027380105053358816
sgpt,0.0027380105053358816
signal,0.0027380105053358816
signals,0.0027380105053358816
silica,0.0027380105053358816
51,0.0027380105053358816
57,0.0027380105053358816
simultaneous,0.0027380105053358816
concluded,0.0027380105053358816
erythropoietin,0.0027380105053358816
governing,0.0027380105053358816
mcc,0.0027380105053358816
isohemagglutinins,0.0027380105053358816
situations,0.0027380105053358816
sjogrens,0.0027380105053358816
sm,0.0027380105053358816
sofa,0.0027380105053358816
specificity,0.0027380105053358816
46,0.0027380105053358816
comprehensive,0.0027380105053358816
computation,0.0027380105053358816
sr,0.0027380105053358816
blockers,0.0027380105053358816
irradiated,0.0027380105053358816
ischemic,0.0027380105053358816
anhydrous,0.0027380105053358816
points,0.0024488411236878883
opinion,0.0024488411236878883
residual,0.0024488411236878883
collected,0.0024488411236878883
thrombosis,0.0024488411236878883
interaction,0.0024488411236878883
7mg,0.0023626784152575965
sponge,0.0023626784152575965
attacks,0.0023626784152575965
stabilization,0.0023626784152575965
administrated,0.0023626784152575965
phosphate,0.0023626784152575965
standards,0.0023626784152575965
cream,0.0023626784152575965
persistence,0.0023626784152575965
efficiency,0.0023626784152575965
schemes,0.0023626784152575965
aspiration,0.0023626784152575965
effectively,0.0023626784152575965
concentrations,0.0023626784152575965
mn,0.0023626784152575965
pharmacodynamic,0.0023626784152575965
d15,0.0023626784152575965
d45,0.0023626784152575965
apparent,0.0023626784152575965
appeared,0.0023626784152575965
medicines,0.0023626784152575965
meier,0.0023626784152575965
randomly,0.0023626784152575965
nature,0.0023626784152575965
org,0.0023626784152575965
epi,0.0023626784152575965
ckd,0.0023626784152575965
functioning,0.0023626784152575965
accrual,0.0023626784152575965
36v2,0.0023626784152575965
country,0.0023626784152575965
unconsciousness,0.0023626784152575965
pancreatitis,0.0023626784152575965
pancytopenia,0.0023626784152575965
gadolinium,0.0023626784152575965
external,0.0023626784152575965
38c,0.0023626784152575965
example,0.0023626784152575965
velocity,0.0023626784152575965
150mg,0.0023626784152575965
treating,0.0023626784152575965
negativation,0.0023626784152575965
neoplasm,0.0023626784152575965
tricuspid,0.0023626784152575965
inactivity,0.0023626784152575965
electrolytes,0.0023626784152575965
true,0.0023626784152575965
3mg,0.0023626784152575965
neutrophiles,0.0023626784152575965
saliva,0.0023626784152575965
haplotype,0.0023626784152575965
signing,0.0023626784152575965
graall2003,0.0023626784152575965
concurrent,0.0023626784152575965
immediately,0.0023626784152575965
gonadic,0.0023626784152575965
sf36,0.0023626784152575965
sectional,0.0023626784152575965
grcs,0.0023626784152575965
settings,0.0023626784152575965
identifying,0.0023626784152575965
gt,0.0023626784152575965
conclusions,0.0023626784152575965
karyotype,0.0023626784152575965
useful,0.0023626784152575965
v1,0.0023626784152575965
simple,0.0023626784152575965
familial,0.0023626784152575965
bowel,0.0023626784152575965
validity,0.0023626784152575965
alterations,0.0023626784152575965
proteasome,0.0023626784152575965
ll03,0.0023626784152575965
shock,0.0023626784152575965
sharing,0.0023626784152575965
shaq,0.0023626784152575965
properly,0.0023626784152575965
enhancement,0.0023626784152575965
implies,0.0023626784152575965
optional,0.0023626784152575965
kaplan,0.0023626784152575965
d100,0.0023626784152575965
glucocorticoid,0.0023626784152575965
cm,0.0023626784152575965
transfused,0.0023626784152575965
combine,0.0023626784152575965
sperm,0.0023626784152575965
cytometry,0.0023626784152575965
monoxide,0.0023626784152575965
sp02,0.0023626784152575965
bvas,0.0023626784152575965
immunologic,0.0023626784152575965
immunomodulation,0.0023626784152575965
angio,0.0023626784152575965
premedication,0.0023626784152575965
disappearance,0.0023626784152575965
disability,0.0023626784152575965
ancillary,0.0023626784152575965
variables,0.0023626784152575965
analyzing,0.0023626784152575965
matching,0.0023626784152575965
proposes,0.0023626784152575965
interview,0.0023626784152575965
caecum,0.0023626784152575965
monocytes,0.0023626784152575965
ligand,0.0023626784152575965
microg,0.0023626784152575965
unaffected,0.0023626784152575965
cap,0.0023626784152575965
bn,0.0023626784152575965
hope,0.0023626784152575965
controlling,0.0023626784152575965
cardio,0.0023626784152575965
telephone,0.0023626784152575965
switzerland,0.0023626784152575965
vod,0.0023626784152575965
occlusive,0.0023626784152575965
encephalitis,0.0023626784152575965
relating,0.0023626784152575965
brutal,0.0023626784152575965
ulceration,0.0023626784152575965
regional,0.0023626784152575965
trv,0.0023626784152575965
verified,0.0023626784152575965
vfq,0.0023626784152575965
ulcerated,0.0023626784152575965
thanks,0.0023626784152575965
correlate,0.0023626784152575965
analyse,0.0023626784152575965
typing,0.0023626784152575965
intra,0.0023626784152575965
expect,0.0023626784152575965
experts,0.0023626784152575965
budesonide,0.0023626784152575965
2006,0.0023626784152575965
oncology,0.0023626784152575965
hcsp,0.0023626784152575965
lost,0.0023626784152575965
website,0.0023626784152575965
edge,0.0023626784152575965
blocks,0.0023626784152575965
aimed,0.0023626784152575965
depressive,0.0023626784152575965
lymphedema,0.0023626784152575965
routine,0.0023626784152575965
file,0.0023626784152575965
way,0.0023626784152575965
rheumatology,0.0023626784152575965
dry,0.0023626784152575965
carbon,0.0023626784152575965
observation,0.0023626784152575965
includes,0.002187518183448572
ongoing,0.002187518183448572
amplification,0.002187518183448572
decision,0.002187518183448572
surgical,0.002071548228421601
scheduled,0.002071548228421601
conduct,0.002071548228421601
chose,0.002071548228421601
comparative,0.002071548228421601
special,0.002071548228421601
graaph,0.002071548228421601
250,0.002071548228421601
essential,0.002071548228421601
alkaline,0.002071548228421601
established,0.002071548228421601
assigned,0.002071548228421601
phosphatase,0.002071548228421601
binomial,0.002071548228421601
match,0.002071548228421601
mass,0.002071548228421601
agreed,0.002071548228421601
intervals,0.002071548228421601
brochure,0.002071548228421601
software,0.002071548228421601
medullar,0.002071548228421601
conjugate,0.002071548228421601
pharmacodynamics,0.002071548228421601
similarly,0.002071548228421601
criss,0.002071548228421601
marker,0.002071548228421601
myocarditis,0.002071548228421601
clinic,0.002071548228421601
serological,0.002071548228421601
distribution,0.002071548228421601
compliance,0.002071548228421601
quantification,0.002071548228421601
contact,0.002071548228421601
hsv,0.002071548228421601
ensuring,0.002071548228421601
updated,0.002071548228421601
continuous,0.002071548228421601
recruited,0.002071548228421601
terminology,0.002071548228421601
maintain,0.002071548228421601
saes,0.002071548228421601
v4,0.002071548228421601
frozen,0.002071548228421601
zero,0.002071548228421601
cd19,0.002071548228421601
block,0.002071548228421601
room,0.002071548228421601
enrollment,0.002071548228421601
sign,0.002071548228421601
creatininuria,0.002071548228421601
doppler,0.002071548228421601
logmar,0.002071548228421601
eq5d,0.002071548228421601
air,0.002071548228421601
paraclinical,0.002071548228421601
reactants,0.002071548228421601
explored,0.002071548228421601
load,0.002071548228421601
decided,0.002071548228421601
priapism,0.002071548228421601
degree,0.002071548228421601
ms,0.002071548228421601
analyze,0.002071548228421601
answer,0.0018336775457106665
class,0.0018336775457106665
identification,0.0018336775457106665
law,0.0018336775457106665
achieved,0.0018336775457106665
allograft,0.0018336775457106665
pfs,0.0018336775457106665
gr,0.0018336775457106665
mmol,0.0018336775457106665
judgment,0.0018336775457106665
modification,0.0018336775457106665
hgf,0.0018336775457106665
occurring,0.0018336775457106665
analysed,0.0018336775457106665
fish,0.0018336775457106665
plan,0.0016325607491252587
https,0.0016325607491252587
flow,0.0016325607491252587
concerning,0.0016325607491252587
investigators,0.0016325607491252587
contraceptionassociated,0.0013690052526679408
respected,0.0013690052526679408
repercussions,0.0013690052526679408
cardiological,0.0013690052526679408
researchers,0.0013690052526679408
restriction,0.0013690052526679408
bashey,0.0013690052526679408
confined,0.0013690052526679408
reticulocytopenia,0.0013690052526679408
retrieved,0.0013690052526679408
h2o,0.0013690052526679408
res,0.0013690052526679408
5q,0.0013690052526679408
representant,0.0013690052526679408
reversible,0.0013690052526679408
senescence,0.0013690052526679408
5mm,0.0013690052526679408
reproducibility,0.0013690052526679408
loghr,0.0013690052526679408
carcinomas,0.0013690052526679408
linearity,0.0013690052526679408
96,0.0013690052526679408
conjugated,0.0013690052526679408
linguistic,0.0013690052526679408
contribute,0.0013690052526679408
liters,0.0013690052526679408
96h,0.0013690052526679408
living,0.0013690052526679408
6mg,0.0013690052526679408
capture,0.0013690052526679408
confound,0.0013690052526679408
b19,0.0013690052526679408
limb,0.0013690052526679408
balanced,0.0013690052526679408
topoisomerase,0.0013690052526679408
60mmhg,0.0013690052526679408
confirmatory,0.0013690052526679408
97,0.0013690052526679408
gregory,0.0013690052526679408
connective,0.0013690052526679408
roactemra,0.0013690052526679408
continuously,0.0013690052526679408
ruxolitinib,0.0013690052526679408
s0,0.0013690052526679408
consequences,0.0013690052526679408
consequently,0.0013690052526679408
treg,0.0013690052526679408
tried,0.0013690052526679408
triggered,0.0013690052526679408
medullary,0.0013690052526679408
ulcer,0.0013690052526679408
tutelle,0.0013690052526679408
circi,0.0013690052526679408
circumference,0.0013690052526679408
circumstance,0.0013690052526679408
cirrhosis,0.0013690052526679408
sat02,0.0013690052526679408
schedules,0.0013690052526679408
turners,0.0013690052526679408
tumoral,0.0013690052526679408
tropical,0.0013690052526679408
epitopes,0.0013690052526679408
eradicate,0.0013690052526679408
eradicated,0.0013690052526679408
rf,0.0013690052526679408
routinely,0.0013690052526679408
rr,0.0013690052526679408
members,0.0013690052526679408
meningoencephalitis,0.0013690052526679408
mental,0.0013690052526679408
mesenteric,0.0013690052526679408
rise,0.0013690052526679408
mianserine,0.0013690052526679408
roth,0.0013690052526679408
ards,0.0013690052526679408
arginine,0.0013690052526679408
roster,0.0013690052526679408
ropinirole,0.0013690052526679408
capable,0.0013690052526679408
arising,0.0013690052526679408
haplomudelederly,0.0013690052526679408
capability,0.0013690052526679408
meter,0.0013690052526679408
richerand,0.0013690052526679408
salt,0.0013690052526679408
separate,0.0013690052526679408
septal,0.0013690052526679408
serologic,0.0013690052526679408
hdcy,0.0013690052526679408
fisher,0.0013690052526679408
fishers,0.0013690052526679408
fistulas,0.0013690052526679408
tuberculin,0.0013690052526679408
traditional,0.0013690052526679408
200mg,0.0013690052526679408
207,0.0013690052526679408
edetate,0.0013690052526679408
transplantations,0.0013690052526679408
edentate,0.0013690052526679408
transport,0.0013690052526679408
transporter,0.0013690052526679408
transporters,0.0013690052526679408
involuntary,0.0013690052526679408
belgium,0.0013690052526679408
schizophrenia,0.0013690052526679408
scl,0.0013690052526679408
sclicc,0.0013690052526679408
guardian,0.0013690052526679408
hbc,0.0013690052526679408
epilepsy,0.0013690052526679408
epinephrine,0.0013690052526679408
75011,0.0013690052526679408
75017,0.0013690052526679408
7ml,0.0013690052526679408
consults,0.0013690052526679408
disturbances,0.0013690052526679408
dlqi,0.0013690052526679408
dme,0.0013690052526679408
doctor,0.0013690052526679408
clearly,0.0013690052526679408
clairance,0.0013690052526679408
melun,0.0013690052526679408
gupta,0.0013690052526679408
gy,0.0013690052526679408
constitutional,0.0013690052526679408
7q,0.0013690052526679408
berry,0.0013690052526679408
bg9588,0.0013690052526679408
donating,0.0013690052526679408
dopamine,0.0013690052526679408
doubling,0.0013690052526679408
dqb1,0.0013690052526679408
draining,0.0013690052526679408
antibacterials,0.0013690052526679408
antidepressants,0.0013690052526679408
supervised,0.0013690052526679408
supports,0.0013690052526679408
suppository,0.0013690052526679408
catherization,0.0013690052526679408
aminoside,0.0013690052526679408
causative,0.0013690052526679408
compatibility,0.0013690052526679408
synechiae,0.0013690052526679408
syphilis,0.0013690052526679408
tca,0.0013690052526679408
technique,0.0013690052526679408
teleconsultation,0.0013690052526679408
telomere,0.0013690052526679408
2d6,0.0013690052526679408
3000,0.0013690052526679408
30min,0.0013690052526679408
thalassemias,0.0013690052526679408
theophylline,0.0013690052526679408
caucasian,0.0013690052526679408
ghsif,0.0013690052526679408
gilz,0.0013690052526679408
stearate,0.0013690052526679408
stearyl,0.0013690052526679408
stents,0.0013690052526679408
fluoropyrimidine,0.0013690052526679408
thrombopoietin,0.0013690052526679408
thymo,0.0013690052526679408
timeframe,0.0013690052526679408
substantial,0.0013690052526679408
subtenons,0.0013690052526679408
sucrose,0.0013690052526679408
biostatistics,0.0013690052526679408
beneficiary,0.0013690052526679408
black,0.0013690052526679408
estrogenic,0.0013690052526679408
strips,0.0013690052526679408
fraumeni,0.0013690052526679408
frequencies,0.0013690052526679408
frequentist,0.0013690052526679408
fumarate,0.0013690052526679408
fungals,0.0013690052526679408
completely,0.0013690052526679408
summarized,0.0013690052526679408
thirty,0.0013690052526679408
thrombocythemia,0.0013690052526679408
belonging,0.0013690052526679408
bipolar,0.0013690052526679408
work,0.0013690052526679408
experiencing,0.0013690052526679408
laboratories,0.0013690052526679408
lactating,0.0013690052526679408
lactation,0.0013690052526679408
lam,0.0013690052526679408
language,0.0013690052526679408
dysgueusia,0.0013690052526679408
dysregulated,0.0013690052526679408
e171,0.0013690052526679408
e172,0.0013690052526679408
eac,0.0013690052526679408
easier,0.0013690052526679408
theorical,0.0013690052526679408
der,0.0013690052526679408
expose,0.0013690052526679408
biggest,0.0013690052526679408
volunteers,0.0013690052526679408
vulnerable,0.0013690052526679408
12p,0.0013690052526679408
cerebrospinal,0.0013690052526679408
107,0.0013690052526679408
045,0.0013690052526679408
wcbp,0.0013690052526679408
follicle,0.0013690052526679408
follicular,0.0013690052526679408
workshop,0.0013690052526679408
easy,0.0013690052526679408
donate,0.0013690052526679408
carriers,0.0013690052526679408
cary,0.0013690052526679408
talc,0.0013690052526679408
flutter,0.0013690052526679408
suppress,0.0013690052526679408
suppressive,0.0013690052526679408
supra,0.0013690052526679408
sur,0.0013690052526679408
surrogacy,0.0013690052526679408
surrogate,0.0013690052526679408
survivals,0.0013690052526679408
susceptibility,0.0013690052526679408
companies,0.0013690052526679408
symptothermal,0.0013690052526679408
join,0.0013690052526679408
apart,0.0013690052526679408
aphtoid,0.0013690052526679408
lymph,0.0013690052526679408
lymphomas,0.0013690052526679408
foster,0.0013690052526679408
fracture,0.0013690052526679408
fralle,0.0013690052526679408
francais,0.0013690052526679408
t1,0.0013690052526679408
t2,0.0013690052526679408
t38c,0.0013690052526679408
community,0.0013690052526679408
sylvie,0.0013690052526679408
4th,0.0013690052526679408
50g,0.0013690052526679408
50mmhg,0.0013690052526679408
tools,0.0013690052526679408
matthieu,0.0013690052526679408
maximal,0.0013690052526679408
anas,0.0013690052526679408
aneurysm,0.0013690052526679408
aneurysms,0.0013690052526679408
animals,0.0013690052526679408
skins,0.0013690052526679408
esomeprazole,0.0013690052526679408
specie,0.0013690052526679408
georges,0.0013690052526679408
spermicidal,0.0013690052526679408
colony,0.0013690052526679408
colorectal,0.0013690052526679408
25mmhg,0.0013690052526679408
264,0.0013690052526679408
tizanidine,0.0013690052526679408
tm,0.0013690052526679408
tonometry,0.0013690052526679408
4000,0.0013690052526679408
40ml,0.0013690052526679408
450,0.0013690052526679408
glass,0.0013690052526679408
globulins,0.0013690052526679408
specificities,0.0013690052526679408
lpf,0.0013690052526679408
fio2,0.0013690052526679408
sh,0.0013690052526679408
signature,0.0013690052526679408
signatures,0.0013690052526679408
anomalies,0.0013690052526679408
anosmia,0.0013690052526679408
mdw,0.0013690052526679408
bosch,0.0013690052526679408
boutboul,0.0013690052526679408
distearate,0.0013690052526679408
distress,0.0013690052526679408
granulocyte,0.0013690052526679408
4n,0.0013690052526679408
simultaneously,0.0013690052526679408
singer,0.0013690052526679408
sinus,0.0013690052526679408
goldmann,0.0013690052526679408
setons,0.0013690052526679408
seven,0.0013690052526679408
sex,0.0013690052526679408
sexually,0.0013690052526679408
sf36v2,0.0013690052526679408
biomarker,0.0013690052526679408
concurrently,0.0013690052526679408
conduction,0.0013690052526679408
sister,0.0013690052526679408
marzouk,0.0013690052526679408
simplex,0.0013690052526679408
spline,0.0013690052526679408
square,0.0013690052526679408
srs2,0.0013690052526679408
stability,0.0013690052526679408
staggered,0.0013690052526679408
steroidal,0.0013690052526679408
stimulating,0.0013690052526679408
stimulation,0.0013690052526679408
stool,0.0013690052526679408
stress,0.0013690052526679408
eta,0.0013690052526679408
ionizing,0.0013690052526679408
iqr,0.0013690052526679408
glycerol,0.0013690052526679408
mannitol,0.0013690052526679408
mapping,0.0013690052526679408
mar,0.0013690052526679408
marfan,0.0013690052526679408
margin,0.0013690052526679408
maria,0.0013690052526679408
36v2tm,0.0013690052526679408
macrogol,0.0013690052526679408
maize,0.0013690052526679408
maladie,0.0013690052526679408
managed,0.0013690052526679408
mandatory,0.0013690052526679408
ef,0.0013690052526679408
manifestation,0.0013690052526679408
glycol,0.0013690052526679408
glycolate,0.0013690052526679408
gm,0.0013690052526679408
gobal,0.0013690052526679408
smd,0.0013690052526679408
smoothing,0.0013690052526679408
smp,0.0013690052526679408
staining,0.0013690052526679408
2124,0.0013690052526679408
lungs,0.0013690052526679408
antiherpetic,0.0013690052526679408
antimalarial,0.0013690052526679408
antitumor,0.0013690052526679408
4ml,0.0013690052526679408
antral,0.0013690052526679408
anymore,0.0013690052526679408
aortic,0.0013690052526679408
iterative,0.0013690052526679408
iusg,0.0013690052526679408
jb,0.0013690052526679408
214,0.0013690052526679408
spiegelhalter,0.0013690052526679408
etdrs,0.0013690052526679408
etonogestrel,0.0013690052526679408
europa,0.0013690052526679408
computing,0.0013690052526679408
470,0.0013690052526679408
4mg,0.0013690052526679408
antivirals,0.0013690052526679408
personalized,0.0013690052526679408
dated,0.0013690052526679408
dates,0.0013690052526679408
decisive,0.0013690052526679408
defect,0.0013690052526679408
defective,0.0013690052526679408
perfusion,0.0013690052526679408
phases,0.0013690052526679408
phenylephrine,0.0013690052526679408
phenytoin,0.0013690052526679408
phlebotomies,0.0013690052526679408
administrative,0.0013690052526679408
admissions,0.0013690052526679408
food,0.0013690052526679408
neoplastic,0.0013690052526679408
nephrostomy,0.0013690052526679408
net,0.0013690052526679408
neurogenic,0.0013690052526679408
neuroimaging,0.0013690052526679408
attempts,0.0013690052526679408
attributable,0.0013690052526679408
ascent,0.0013690052526679408
aspects,0.0013690052526679408
insult,0.0013690052526679408
intact,0.0013690052526679408
nci,0.0013690052526679408
nct01795677,0.0013690052526679408
neoplasms,0.0013690052526679408
panels,0.0013690052526679408
pao,0.0013690052526679408
danlos,0.0013690052526679408
causing,0.0013690052526679408
cavity,0.0013690052526679408
cd14,0.0013690052526679408
veino,0.0013690052526679408
vera,0.0013690052526679408
verbal,0.0013690052526679408
verification,0.0013690052526679408
16s,0.0013690052526679408
172,0.0013690052526679408
17q,0.0013690052526679408
persistant,0.0013690052526679408
brca,0.0013690052526679408
pericardial,0.0013690052526679408
perinephric,0.0013690052526679408
patriarca,0.0013690052526679408
imputable,0.0013690052526679408
inability,0.0013690052526679408
incapacity,0.0013690052526679408
incarcerated,0.0013690052526679408
pbmcs,0.0013690052526679408
peak,0.0013690052526679408
pectoral,0.0013690052526679408
peep,0.0013690052526679408
nevous,0.0013690052526679408
bmi,0.0013690052526679408
188,0.0013690052526679408
nasopharyngeal,0.0013690052526679408
arthralgia,0.0013690052526679408
artpo,0.0013690052526679408
posteriori,0.0013690052526679408
additionally,0.0013690052526679408
cyp,0.0013690052526679408
imp,0.0013690052526679408
impacts,0.0013690052526679408
impairing,0.0013690052526679408
impeding,0.0013690052526679408
implant,0.0013690052526679408
bile,0.0013690052526679408
cystic,0.0013690052526679408
neck,0.0013690052526679408
cytogenetics,0.0013690052526679408
cytologic,0.0013690052526679408
cytology,0.0013690052526679408
cytomegalovirus,0.0013690052526679408
adjudicated,0.0013690052526679408
practitioners,0.0013690052526679408
precipitating,0.0013690052526679408
dialysis,0.0013690052526679408
dibasic,0.0013690052526679408
diet,0.0013690052526679408
difficile,0.0013690052526679408
immunomodulator,0.0013690052526679408
immunomonitoring,0.0013690052526679408
premenopausal,0.0013690052526679408
cytochromes,0.0013690052526679408
needing,0.0013690052526679408
pfu,0.0013690052526679408
play,0.0013690052526679408
pneumocystis,0.0013690052526679408
lasting,0.0013690052526679408
latex,0.0013690052526679408
lbs,0.0013690052526679408
leclerc,0.0013690052526679408
aphtosis,0.0013690052526679408
bioactivity,0.0013690052526679408
biochemical,0.0013690052526679408
exposing,0.0013690052526679408
admitted,0.0013690052526679408
myeloblative,0.0013690052526679408
atherosclerosis,0.0013690052526679408
poloxamer,0.0013690052526679408
polycythemia,0.0013690052526679408
polymerase,0.0013690052526679408
polysorbate,0.0013690052526679408
porphyria,0.0013690052526679408
pose,0.0013690052526679408
impossible,0.0013690052526679408
impressive,0.0013690052526679408
pills,0.0013690052526679408
plasmablasts,0.0013690052526679408
cytoreductive,0.0013690052526679408
diffusing,0.0013690052526679408
diffusion,0.0013690052526679408
atelectasis,0.0013690052526679408
oliguria,0.0013690052526679408
online,0.0013690052526679408
ono,0.0013690052526679408
oozing,0.0013690052526679408
opacification,0.0013690052526679408
opacities,0.0013690052526679408
descriptive,0.0013690052526679408
designees,0.0013690052526679408
obstructive,0.0013690052526679408
obtention,0.0013690052526679408
indwelling,0.0013690052526679408
injectables,0.0013690052526679408
innate,0.0013690052526679408
patientsfiles,0.0013690052526679408
norepinephrine,0.0013690052526679408
notebook,0.0013690052526679408
agonists,0.0013690052526679408
brother,0.0013690052526679408
ineligible,0.0013690052526679408
infants,0.0013690052526679408
obvious,0.0013690052526679408
occupational,0.0013690052526679408
encephalopathy,0.0013690052526679408
1981,0.0013690052526679408
vi,0.0013690052526679408
views,0.0013690052526679408
vigorous,0.0013690052526679408
bmdw,0.0013690052526679408
xanthine,0.0013690052526679408
exploring,0.0013690052526679408
124,0.0013690052526679408
11q23,0.0013690052526679408
withdrawals,0.0013690052526679408
wittes,0.0013690052526679408
weighting,0.0013690052526679408
whevener,0.0013690052526679408
widal,0.0013690052526679408
wilcoxons,0.0013690052526679408
window,0.0013690052526679408
wish,0.0013690052526679408
excipient,0.0013690052526679408
occurence,0.0013690052526679408
expired,0.0013690052526679408
johnson,0.0013690052526679408
asplenia,0.0013690052526679408
assessments,0.0013690052526679408
assignee,0.0013690052526679408
assumptions,0.0013690052526679408
allele,0.0013690052526679408
allergy,0.0013690052526679408
allocation,0.0013690052526679408
nsaids,0.0013690052526679408
nucleocapsid,0.0013690052526679408
nutritional,0.0013690052526679408
obesity,0.0013690052526679408
depleting,0.0013690052526679408
cellulaire,0.0013690052526679408
indicative,0.0013690052526679408
optimizing,0.0013690052526679408
ordinal,0.0013690052526679408
paoli,0.0013690052526679408
pap,0.0013690052526679408
paramedical,0.0013690052526679408
parasitic,0.0013690052526679408
parental,0.0013690052526679408
defining,0.0013690052526679408
deletion,0.0013690052526679408
demonstration,0.0013690052526679408
br3,0.0013690052526679408
packages,0.0013690052526679408
chain,0.0013690052526679408
ehlers,0.0013690052526679408
elaborate,0.0013690052526679408
instructions,0.0013690052526679408
breakage,0.0013690052526679408
broad,0.0013690052526679408
parenterally,0.0013690052526679408
aesi,0.0013690052526679408
affective,0.0013690052526679408
parvovirus,0.0013690052526679408
patches,0.0013690052526679408
pathogens,0.0013690052526679408
pathologic,0.0013690052526679408
pathologies,0.0013690052526679408
pathophysiology,0.0013690052526679408
effort,0.0013690052526679408
chained,0.0013690052526679408
changed,0.0013690052526679408
vii,0.0013690052526679408
viii,0.0013690052526679408
expectancy,0.0013690052526679408
ophthalmic,0.0013690052526679408
organized,0.0013690052526679408
overproduction,0.0013690052526679408
owing,0.0013690052526679408
oxide,0.0013690052526679408
ozurdex,0.0013690052526679408
p450,0.0013690052526679408
pac02,0.0013690052526679408
paediatric,0.0013690052526679408
dependance,0.0013690052526679408
agreeing,0.0013690052526679408
elimination,0.0013690052526679408
ellenberg,0.0013690052526679408
embolism,0.0013690052526679408
empirically,0.0013690052526679408
dhtr,0.0013690052526679408
nineteen,0.0013690052526679408
node,0.0013690052526679408
nodules,0.0013690052526679408
nomegestrol,0.0013690052526679408
nonparametric,0.0013690052526679408
infiltrating,0.0013690052526679408
paco2,0.0013690052526679408
denotes,0.0013690052526679408
accelerate,0.0013690052526679408
accessed,0.0013690052526679408
corticotrophin,0.0013690052526679408
costimulation,0.0013690052526679408
cotrimoxazole,0.0013690052526679408
unexposed,0.0013690052526679408
unfit,0.0013690052526679408
universelle,0.0013690052526679408
universitaire,0.0013690052526679408
cd40l,0.0013690052526679408
excellent,0.0013690052526679408
excepted,0.0013690052526679408
exception,0.0013690052526679408
valued,0.0013690052526679408
cousin,0.0013690052526679408
accrued,0.0013690052526679408
acetate,0.0013690052526679408
9th,0.0013690052526679408
abetimus,0.0013690052526679408
absolue,0.0013690052526679408
enterocystoplasty,0.0013690052526679408
authorizing,0.0013690052526679408
realize,0.0013690052526679408
mid,0.0013690052526679408
miller,0.0013690052526679408
mirtazapine,0.0013690052526679408
eot,0.0013690052526679408
couple,0.0013690052526679408
qaly,0.0013690052526679408
qualify,0.0013690052526679408
crisis,0.0013690052526679408
crospovidone,0.0013690052526679408
mo,0.0013690052526679408
modeling,0.0013690052526679408
modifications,0.0013690052526679408
modifies,0.0013690052526679408
mole,0.0013690052526679408
monobasic,0.0013690052526679408
rating,0.0013690052526679408
couverture,0.0013690052526679408
cover,0.0013690052526679408
realized,0.0013690052526679408
quinolones,0.0013690052526679408
av,0.0013690052526679408
avascular,0.0013690052526679408
hyperacute,0.0013690052526679408
favourably,0.0013690052526679408
chronology,0.0013690052526679408
covered,0.0013690052526679408
cps,0.0013690052526679408
cr1,0.0013690052526679408
creates,0.0013690052526679408
creatininemia,0.0013690052526679408
hour,0.0013690052526679408
hrct,0.0013690052526679408
ranieri,0.0013690052526679408
quasi,0.0013690052526679408
hematuria,0.0013690052526679408
hemopathy,0.0013690052526679408
hepatocyte,0.0013690052526679408
her2,0.0013690052526679408
avoided,0.0013690052526679408
rehospitalizations,0.0013690052526679408
barnich,0.0013690052526679408
discussion,0.0013690052526679408
diseappearance,0.0013690052526679408
displaying,0.0013690052526679408
dissection,0.0013690052526679408
bonne,0.0013690052526679408
book,0.0013690052526679408
hodgkins,0.0013690052526679408
reset,0.0013690052526679408
residuals,0.0013690052526679408
82,0.0013690052526679408
8mg,0.0013690052526679408
caps,0.0013690052526679408
capsular,0.0013690052526679408
histological,0.0013690052526679408
historically,0.0013690052526679408
enrolling,0.0013690052526679408
reinforced,0.0013690052526679408
relatively,0.0013690052526679408
relies,0.0013690052526679408
rely,0.0013690052526679408
microangiopathic,0.0013690052526679408
boost,0.0013690052526679408
hold,0.0013690052526679408
kdigo2012,0.0013690052526679408
killed,0.0013690052526679408
dual,0.0013690052526679408
duct,0.0013690052526679408
dusp,0.0013690052526679408
li,0.0013690052526679408
uncertainty,0.0013690052526679408
homeless,0.0013690052526679408
refers,0.0013690052526679408
refrain,0.0013690052526679408
cooperative,0.0013690052526679408
correct,0.0013690052526679408
remissions,0.0013690052526679408
regress,0.0013690052526679408
microsined,0.0013690052526679408
inv,0.0013690052526679408
aptt,0.0013690052526679408
anal,0.0013690052526679408
histidine,0.0013690052526679408
1b,0.0013690052526679408
1g,0.0013690052526679408
feasible,0.0013690052526679408
fernand,0.0013690052526679408
fetal,0.0013690052526679408
fibrillation,0.0013690052526679408
1x109,0.0013690052526679408
umr,0.0013690052526679408
correlations,0.0013690052526679408
prevents,0.0013690052526679408
priority,0.0013690052526679408
prisoners,0.0013690052526679408
probabilities,0.0013690052526679408
probenecid,0.0013690052526679408
prescribing,0.0013690052526679408
preservation,0.0013690052526679408
engagement,0.0013690052526679408
ureteral,0.0013690052526679408
urologic,0.0013690052526679408
uveal,0.0013690052526679408
facilitate,0.0013690052526679408
fall,0.0013690052526679408
q3w,0.0013690052526679408
faster,0.0013690052526679408
vaccination,0.0013690052526679408
validation,0.0013690052526679408
ileitis,0.0013690052526679408
problem,0.0013690052526679408
proceed,0.0013690052526679408
prof,0.0013690052526679408
profiling,0.0013690052526679408
profound,0.0013690052526679408
prohibit,0.0013690052526679408
proinflammatory,0.0013690052526679408
proliferative,0.0013690052526679408
promoted,0.0013690052526679408
property,0.0013690052526679408
fanconi,0.0013690052526679408
valves,0.0013690052526679408
variation,0.0013690052526679408
vasectomized,0.0013690052526679408
vasopressin,0.0013690052526679408
vasopressor,0.0013690052526679408
vault,0.0013690052526679408
vein,0.0013690052526679408
checkpoints,0.0013690052526679408
interpretation,0.0013690052526679408
interrogating,0.0013690052526679408
multicentricity,0.0013690052526679408
murin,0.0013690052526679408
muscles,0.0013690052526679408
acyclovir,0.0013690052526679408
predictor,0.0013690052526679408
predictors,0.0013690052526679408
predisposition,0.0013690052526679408
preferable,0.0013690052526679408
pregelatinized,0.0013690052526679408
image,0.0013690052526679408
imbalances,0.0013690052526679408
activities,0.0013690052526679408
calendar,0.0013690052526679408
calmettes,0.0013690052526679408
calprotectin,0.0013690052526679408
cut,0.0013690052526679408
cyclophophamide,0.0013690052526679408
cylinders,0.0013690052526679408
prevalance,0.0013690052526679408
monogamous,0.0013690052526679408
morality,0.0013690052526679408
pugnet,0.0013690052526679408
pumonary,0.0013690052526679408
puncture,0.0013690052526679408
provisional,0.0013690052526679408
ideation,0.0013690052526679408
cryoglobulin,0.0013690052526679408
cryoglobulinemic,0.0013690052526679408
quarterly,0.0013690052526679408
unpublished,0.0013690052526679408
unresectable,0.0013690052526679408
leucocyte,0.0013690052526679408
csi,0.0013690052526679408
dramatic,0.0013690052526679408
drb1,0.0013690052526679408
jy,0.0013690052526679408
kappa,0.0013690052526679408
unresolved,0.0013690052526679408
unresponsive,0.0013690052526679408
hyperthermia,0.0013690052526679408
hypofertility,0.0013690052526679408
hypoxia,0.0013690052526679408
raj,0.0013690052526679408
ranging,0.0013690052526679408
pure,0.0013690052526679408
pursuant,0.0013690052526679408
pyuria,0.0013690052526679408
levonorgestrel,0.0013690052526679408
endoscope,0.0013690052526679408
endotype,0.0013690052526679408
engaged,0.0013690052526679408
propylene,0.0013690052526679408
prostatic,0.0013690052526679408
achievable,0.0013690052526679408
acquisition,0.0013690052526679408
protected,0.0013690052526679408
alloreactivity,0.0013690052526679408
amazzough,0.0013690052526679408
interestingly,0.0013690052526679408
interfering,0.0013690052526679408
ile,0.0013690052526679408
discovered,0.0013690052526679408
ihc,0.0013690052526679408
enclosed,0.0013690052526679408
encoded,0.0013690052526679408
endocan,0.0013690052526679408
endocarditis,0.0013690052526679408
przepiorka,0.0013690052526679408
psychiatrist,0.0013690052526679408
psychological,0.0013690052526679408
psychosis,0.0013690052526679408
ctla4,0.0013690052526679408
unstable,0.0013690052526679408
unsuitable,0.0013690052526679408
pt1,0.0013690052526679408
dipropionate,0.0013690052526679408
idec,0.0013690052526679408
worthy,0.0011813392076287983
woman,0.0011813392076287983
opioid,0.0011813392076287983
electrophoresis,0.0011813392076287983
agreement,0.0011813392076287983
density,0.0011813392076287983
dendritic,0.0011813392076287983
ovarian,0.0011813392076287983
orr,0.0011813392076287983
pains,0.0011813392076287983
partners,0.0011813392076287983
agency,0.0011813392076287983
sum,0.0011813392076287983
gel,0.0011813392076287983
gastroenterology,0.0011813392076287983
subpopulations,0.0011813392076287983
subgroup,0.0011813392076287983
fluids,0.0011813392076287983
bias,0.0011813392076287983
betamethasone,0.0011813392076287983
fulfilled,0.0011813392076287983
fsh,0.0011813392076287983
antigens,0.0011813392076287983
anticoagulants,0.0011813392076287983
globally,0.0011813392076287983
antinuclear,0.0011813392076287983
48h,0.0011813392076287983
compute,0.0011813392076287983
composed,0.0011813392076287983
isoniazid,0.0011813392076287983
strictly,0.0011813392076287983
stratum,0.0011813392076287983
stevens,0.0011813392076287983
blinding,0.0011813392076287983
magnesium,0.0011813392076287983
mab,0.0011813392076287983
slicc,0.0011813392076287983
sizes,0.0011813392076287983
mcr,0.0011813392076287983
tomographic,0.0011813392076287983
close,0.0011813392076287983
24h,0.0011813392076287983
combining,0.0011813392076287983
collections,0.0011813392076287983
spermogram,0.0011813392076287983
specimens,0.0011813392076287983
species,0.0011813392076287983
spc,0.0011813392076287983
sonography,0.0011813392076287983
snellen,0.0011813392076287983
glucose,0.0011813392076287983
glomerulonephritis,0.0011813392076287983
confounding,0.0011813392076287983
confirmation,0.0011813392076287983
finite,0.0011813392076287983
financial,0.0011813392076287983
greatly,0.0011813392076287983
boulevard,0.0011813392076287983
means,0.0011813392076287983
meaning,0.0011813392076287983
anonymous,0.0011813392076287983
shows,0.0011813392076287983
concerns,0.0011813392076287983
simon,0.0011813392076287983
estimates,0.0011813392076287983
esr,0.0011813392076287983
parity,0.0011813392076287983
venous,0.0011813392076287983
extreme,0.0011813392076287983
electronic,0.0011813392076287983
pbmc,0.0011813392076287983
periodic,0.0011813392076287983
performing,0.0011813392076287983
performans,0.0011813392076287983
personal,0.0011813392076287983
neuropathy,0.0011813392076287983
adjustment,0.0011813392076287983
phenotype,0.0011813392076287983
guide,0.0011813392076287983
transformed,0.0011813392076287983
transferrin,0.0011813392076287983
20mg,0.0011813392076287983
transcriptomic,0.0011813392076287983
5d,0.0011813392076287983
serologies,0.0011813392076287983
sent,0.0011813392076287983
selective,0.0011813392076287983
haemoglobin,0.0011813392076287983
hads,0.0011813392076287983
congenital,0.0011813392076287983
harvest,0.0011813392076287983
handling,0.0011813392076287983
truncation,0.0011813392076287983
troponin,0.0011813392076287983
transverse,0.0011813392076287983
transthoracic,0.0011813392076287983
considers,0.0011813392076287983
75475,0.0011813392076287983
episode,0.0011813392076287983
secondly,0.0011813392076287983
scored,0.0011813392076287983
saturation,0.0011813392076287983
consultations,0.0011813392076287983
meetings,0.0011813392076287983
resources,0.0011813392076287983
94,0.0011813392076287983
tyrosine,0.0011813392076287983
tyndall,0.0011813392076287983
tumour,0.0011813392076287983
classified,0.0011813392076287983
rifampicin,0.0011813392076287983
hematocrit,0.0011813392076287983
held,0.0011813392076287983
equation,0.0011813392076287983
eq,0.0011813392076287983
episodes,0.0011813392076287983
contained,0.0011813392076287983
contain,0.0011813392076287983
rnaemia,0.0011813392076287983
referred,0.0011813392076287983
fields,0.0011813392076287983
fev1,0.0011813392076287983
febrile,0.0011813392076287983
1994,0.0011813392076287983
distance,0.0011813392076287983
avoiding,0.0011813392076287983
replication,0.0011813392076287983
amenorrhea,0.0011813392076287983
investment,0.0011813392076287983
reticulocyte,0.0011813392076287983
respective,0.0011813392076287983
recoveries,0.0011813392076287983
lh,0.0011813392076287983
droplet,0.0011813392076287983
kinase,0.0011813392076287983
keratitis,0.0011813392076287983
kept,0.0011813392076287983
kawasaki,0.0011813392076287983
minimize,0.0011813392076287983
introducing,0.0011813392076287983
regulations,0.0011813392076287983
corpuscular,0.0011813392076287983
refusal,0.0011813392076287983
aseptic,0.0011813392076287983
biobanking,0.0011813392076287983
ldh,0.0011813392076287983
laws,0.0011813392076287983
latest,0.0011813392076287983
d7,0.0011813392076287983
d21,0.0011813392076287983
planning,0.0011813392076287983
auricular,0.0011813392076287983
asthma,0.0011813392076287983
immunosuppressives,0.0011813392076287983
native,0.0011813392076287983
possibly,0.0011813392076287983
precluding,0.0011813392076287983
precision,0.0011813392076287983
hrqol,0.0011813392076287983
ratios,0.0011813392076287983
cpp,0.0011813392076287983
fatal,0.0011813392076287983
units,0.0011813392076287983
uniform,0.0011813392076287983
countries,0.0011813392076287983
corresponds,0.0011813392076287983
accordingly,0.0011813392076287983
reasonable,0.0011813392076287983
entering,0.0011813392076287983
ptt,0.0011813392076287983
mononeuropathy,0.0011813392076287983
discontinue,0.0011813392076287983
application,0.0011813392076287983
crossed,0.0011813392076287983
availability,0.0011813392076287983
questionaire,0.0011813392076287983
dilatation,0.0011813392076287983
moment,0.0011813392076287983
adjusted,0.0011813392076287983
adjudication,0.0011813392076287983
adhesive,0.0011813392076287983
adequately,0.0011813392076287983
vasoconstrictor,0.0011813392076287983
variants,0.0011813392076287983
variable,0.0011813392076287983
immuno,0.0011813392076287983
myelitis,0.0011813392076287983
muscular,0.0011813392076287983
multidisciplinary,0.0011813392076287983
mucosa,0.0011813392076287983
interruption,0.0011813392076287983
interpreted,0.0011813392076287983
primarily,0.0011813392076287983
actually,0.0011813392076287983
falls,0.0011813392076287983
enrol,0.0011813392076287983
intercurrent,0.0011813392076287983
intention,0.0011813392076287983
mos,0.0011813392076287983
alternatively,0.0011813392076287983
alteration,0.0011813392076287983
prothrombin,0.0011813392076287983
achieving,0.0011813392076287983
proposal,0.0011813392076287983
ps,0.0011813392076287983
ending,0.0011813392076287983
censored,0.0011813392076287983
lactate,0.0011813392076287983
nursing,0.0011813392076287983
null,0.0011813392076287983
censoring,0.0011813392076287983
obtaining,0.0011813392076287983
desire,0.0011813392076287983
derivatives,0.0011813392076287983
oestrogen,0.0011813392076287983
normalized,0.0011813392076287983
influenza,0.0011813392076287983
opioids,0.0011813392076287983
donation,0.0011813392076287983
testosterone,0.0011813392076287983
30g,0.0011813392076287983
termination,0.0011813392076287983
sustaining,0.0011813392076287983
susceptible,0.0011813392076287983
categories,0.0011813392076287983
carrying,0.0011813392076287983
comorbidities,0.0011813392076287983
tachycardia,0.0011813392076287983
lvef,0.0011813392076287983
journal,0.0011813392076287983
wang,0.0011813392076287983
walk,0.0011813392076287983
comorbidity,0.0010357741142108005
tarte,0.0010357741142108005
description,0.0010357741142108005
depending,0.0010357741142108005
easily,0.0010357741142108005
c3,0.0010357741142108005
immunization,0.0010357741142108005
c30,0.0010357741142108005
checkpoint,0.0010357741142108005
monitored,0.0010357741142108005
access,0.0010357741142108005
questions,0.0010357741142108005
radiological,0.0010357741142108005
random,0.0010357741142108005
purpose,0.0010357741142108005
qlq,0.0010357741142108005
discharge,0.0010357741142108005
autoantibodies,0.0010357741142108005
minor,0.0010357741142108005
reaches,0.0010357741142108005
eortc,0.0010357741142108005
later,0.0010357741142108005
ab,0.0010357741142108005
replaced,0.0010357741142108005
involve,0.0010357741142108005
abnormality,0.0010357741142108005
charlson,0.0010357741142108005
ch50,0.0010357741142108005
paper,0.0010357741142108005
hospitalisation,0.0010357741142108005
area,0.0010357741142108005
medium,0.0010357741142108005
sequentially,0.0010357741142108005
sedimentation,0.0010357741142108005
independently,0.0010357741142108005
persons,0.0010357741142108005
5l,0.0010357741142108005
auc,0.0010357741142108005
statistics,0.0010357741142108005
stated,0.0010357741142108005
make,0.0010357741142108005
biology,0.0010357741142108005
check,0.0010357741142108005
fresh,0.0010357741142108005
subpopulation,0.0010357741142108005
indicating,0.0010357741142108005
fluid,0.0010357741142108005
subgroups,0.0010357741142108005
detailed,0.0009168387728553332
cr,0.0009168387728553332
real,0.0009168387728553332
biomedical,0.0009168387728553332
cohorts,0.0009168387728553332
erythrocyte,0.0009168387728553332
institut,0.0009168387728553332
perform,0.0008162803745626294
refer,0.0008162803745626294
medications,0.0008162803745626294
